| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 1.67e-07 | 20 | 132 | 5 | GO:0061665 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 3.74e-06 | 36 | 132 | 5 | GO:0019789 | |
| GeneOntologyMolecularFunction | glutathione binding | 5.20e-06 | 18 | 132 | 4 | GO:0043295 | |
| GeneOntologyMolecularFunction | oligopeptide binding | 8.14e-06 | 20 | 132 | 4 | GO:1900750 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 1.95e-05 | 50 | 132 | 5 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 2.60e-05 | 53 | 132 | 5 | GO:0016859 | |
| GeneOntologyMolecularFunction | MHC class II protein complex binding | 2.85e-05 | 27 | 132 | 4 | GO:0023026 | |
| GeneOntologyMolecularFunction | glutathione transferase activity | 3.81e-05 | 29 | 132 | 4 | GO:0004364 | |
| GeneOntologyMolecularFunction | MHC class II receptor activity | 4.48e-05 | 11 | 132 | 3 | GO:0032395 | |
| GeneOntologyMolecularFunction | small GTPase binding | UNC13B RGPD2 RANBP2 RGPD8 RGPD1 GRIA1 RGPD3 USP6NL RAC1 SORL1 | 5.54e-05 | 321 | 132 | 10 | GO:0031267 |
| GeneOntologyMolecularFunction | GTPase binding | UNC13B RGPD2 RANBP2 RGPD8 RGPD1 GRIA1 RGPD3 USP6NL RAC1 SORL1 | 1.43e-04 | 360 | 132 | 10 | GO:0051020 |
| GeneOntologyMolecularFunction | MHC protein complex binding | 1.53e-04 | 41 | 132 | 4 | GO:0023023 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration | 2.58e-04 | 4 | 132 | 2 | GO:0099583 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 3.07e-04 | 49 | 132 | 4 | GO:0042605 | |
| GeneOntologyMolecularFunction | GTP-dependent protein binding | 5.16e-04 | 24 | 132 | 3 | GO:0030742 | |
| GeneOntologyMolecularFunction | cytoskeletal anchor activity | 5.16e-04 | 24 | 132 | 3 | GO:0008093 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 5.43e-04 | 279 | 132 | 8 | GO:0005096 | |
| GeneOntologyMolecularFunction | amide binding | 8.53e-04 | 299 | 132 | 8 | GO:0033218 | |
| GeneOntologyMolecularFunction | transferase activity, transferring alkyl or aryl (other than methyl) groups | 8.53e-04 | 64 | 132 | 4 | GO:0016765 | |
| GeneOntologyMolecularFunction | modified amino acid binding | 1.31e-03 | 122 | 132 | 5 | GO:0072341 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 1.33e-03 | 398 | 132 | 9 | GO:0061659 | |
| GeneOntologyMolecularFunction | beta-2 adrenergic receptor binding | 1.89e-03 | 10 | 132 | 2 | GO:0031698 | |
| GeneOntologyMolecularFunction | acyltransferase activity | RGPD2 RANBP2 RGPD8 RGPD1 G2E3 RSPRY1 TRIM3 NEDD4 FASN SAT1 RGPD3 NAT10 UHRF1 | 1.89e-03 | 775 | 132 | 13 | GO:0016746 |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 1.18e-09 | 9 | 131 | 5 | GO:0033133 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 2.11e-09 | 20 | 131 | 6 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 2.35e-09 | 10 | 131 | 5 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 1.18e-08 | 13 | 131 | 5 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 1.83e-08 | 14 | 131 | 5 | GO:1903299 | |
| GeneOntologyBiologicalProcess | nitrobenzene metabolic process | 9.97e-07 | 4 | 131 | 3 | GO:0018916 | |
| GeneOntologyBiologicalProcess | MHC class II protein complex assembly | 2.67e-06 | 16 | 131 | 4 | GO:0002399 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC class II protein complex | 2.67e-06 | 16 | 131 | 4 | GO:0002503 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 3.54e-06 | 37 | 131 | 5 | GO:0042178 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 4.06e-06 | 38 | 131 | 5 | GO:0000413 | |
| GeneOntologyBiologicalProcess | MHC protein complex assembly | 8.55e-06 | 21 | 131 | 4 | GO:0002396 | |
| GeneOntologyBiologicalProcess | peptide antigen assembly with MHC protein complex | 8.55e-06 | 21 | 131 | 4 | GO:0002501 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 2.36e-05 | 54 | 131 | 5 | GO:0018208 | |
| GeneOntologyBiologicalProcess | nuclear export | 2.43e-05 | 185 | 131 | 8 | GO:0051168 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous antigen | 3.35e-05 | 58 | 131 | 5 | GO:0019884 | |
| GeneOntologyBiologicalProcess | mRNA transport | 3.96e-05 | 145 | 131 | 7 | GO:0051028 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class II | 4.87e-05 | 32 | 131 | 4 | GO:0019886 | |
| GeneOntologyBiologicalProcess | modulation of inhibitory postsynaptic potential | 5.28e-05 | 12 | 131 | 3 | GO:0098828 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | RGPD2 RANBP2 RELN RGPD8 PDGFRB ARHGEF5 HLA-DRB1 RGPD1 CAMK1 RGPD3 ADAM17 | 5.63e-05 | 405 | 131 | 11 | GO:0033674 |
| GeneOntologyBiologicalProcess | protein localization to organelle | RGPD2 RANBP2 RGPD8 MAP1A USP9X RGPD1 OBSL1 AP3B1 BCS1L TERF2IP NEDD4 CEP350 MGAT3 RGPD3 SEC16A GPR137B RAC2 SORL1 RGPD5 | 5.99e-05 | 1091 | 131 | 19 | GO:0033365 |
| GeneOntologyBiologicalProcess | RNA localization | 7.53e-05 | 217 | 131 | 8 | GO:0006403 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class II | 7.82e-05 | 36 | 131 | 4 | GO:0002495 | |
| GeneOntologyBiologicalProcess | positive regulation of dendritic spine development | 8.32e-05 | 70 | 131 | 5 | GO:0060999 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 8.91e-05 | 71 | 131 | 5 | GO:0006111 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | UNC13B RELN MAP1A GRIA1 GRM1 TENM2 CHRNA2 NEDD4 NLGN3 FCHSD2 PTPRA BAIAP2 BSN BAIAP3 CDH8 RAC1 RAC3 | 9.51e-05 | 939 | 131 | 17 | GO:0099537 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 9.70e-05 | 38 | 131 | 4 | GO:0002504 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | RGPD2 RANBP2 RGPD8 USP9X RGPD1 AP3B1 BCS1L NEDD4 RGPD3 RAC2 SORL1 RGPD5 | 1.11e-04 | 515 | 131 | 12 | GO:0072594 |
| GeneOntologyBiologicalProcess | RNA transport | 1.29e-04 | 175 | 131 | 7 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 1.29e-04 | 175 | 131 | 7 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 1.44e-04 | 178 | 131 | 7 | GO:0051236 | |
| GeneOntologyBiologicalProcess | synaptic signaling | UNC13B RELN MAP1A GRIA1 GRM1 TENM2 CHRNA2 NEDD4 NLGN3 FCHSD2 PTPRA BAIAP2 BSN BAIAP3 CDH8 RAC1 RAC3 | 1.51e-04 | 976 | 131 | 17 | GO:0099536 |
| GeneOntologyBiologicalProcess | nuclear transport | RGPD2 RANBP2 RGPD8 RBM33 RGPD1 CAMK1 NEDD4 NCBP2 RGPD3 RGPD5 | 1.53e-04 | 378 | 131 | 10 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | RGPD2 RANBP2 RGPD8 RBM33 RGPD1 CAMK1 NEDD4 NCBP2 RGPD3 RGPD5 | 1.53e-04 | 378 | 131 | 10 | GO:0006913 |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 1.54e-04 | 180 | 131 | 7 | GO:0060078 | |
| GeneOntologyBiologicalProcess | respiratory burst | 1.58e-04 | 43 | 131 | 4 | GO:0045730 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | PDCD1 HLA-DQB2 HLA-DRB1 HLA-DRB4 HLA-DRB5 AP3B1 TENM2 NLGN3 HMCN2 VNN1 SMARCC2 BAIAP2 FGL1 MPZL2 CDH8 CDH13 CDH15 RAC2 | 1.60e-04 | 1077 | 131 | 18 | GO:0098609 |
| GeneOntologyBiologicalProcess | cell morphogenesis | RELN MAP1A USP9X OBSL1 TWF2 AP3B1 TENM2 ATL1 NEDD4 ENAM NLGN3 HMCN2 ADAM17 BAIAP2 CDH8 CDH13 CDH15 RAC1 RAC3 | 1.95e-04 | 1194 | 131 | 19 | GO:0000902 |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 1.99e-04 | 132 | 131 | 6 | GO:0035249 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 2.16e-04 | 134 | 131 | 6 | GO:0010906 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen | 2.44e-04 | 48 | 131 | 4 | GO:0002478 | |
| GeneOntologyBiologicalProcess | axonogenesis | RELN MAP1A USP9X TWF2 TENM2 ATL1 NLGN3 HMCN2 ADAM17 BAIAP2 RAC1 RAC3 | 2.66e-04 | 566 | 131 | 12 | GO:0007409 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | UNC13B RELN MAP1A GRIA1 GRM1 CHRNA2 NEDD4 NLGN3 FCHSD2 PTPRA BAIAP2 BSN BAIAP3 CDH8 RAC1 RAC3 | 2.79e-04 | 931 | 131 | 16 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | UNC13B RELN MAP1A GRIA1 GRM1 CHRNA2 NEDD4 NLGN3 FCHSD2 PTPRA BAIAP2 BSN BAIAP3 CDH8 RAC1 RAC3 | 2.79e-04 | 931 | 131 | 16 | GO:0007268 |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 2.85e-04 | 141 | 131 | 6 | GO:0006805 | |
| GeneOntologyBiologicalProcess | regulation of dendritic spine development | 2.88e-04 | 91 | 131 | 5 | GO:0060998 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | RELN MAP1A USP9X OBSL1 TWF2 TENM2 ATL1 NEDD4 NLGN3 HMCN2 ADAM17 BAIAP2 RAC1 RAC3 | 2.93e-04 | 748 | 131 | 14 | GO:0048667 |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | RGPD2 RANBP2 RELN RGPD8 PDGFRB ARHGEF5 HLA-DRB1 RGPD1 CAMK1 RGPD3 ADAM17 | 2.98e-04 | 490 | 131 | 11 | GO:0051347 |
| GeneOntologyBiologicalProcess | postsynapse assembly | 3.18e-04 | 93 | 131 | 5 | GO:0099068 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | UNC13B MAP1A ARHGEF5 HLA-DRB1 CAMK1 NLGN3 MGAT3 GPR137B BAIAP3 RAC1 RAC2 SORL1 | 3.92e-04 | 591 | 131 | 12 | GO:1903829 |
| GeneOntologyBiologicalProcess | positive regulation of AMPA receptor activity | 3.95e-04 | 5 | 131 | 2 | GO:2000969 | |
| GeneOntologyBiologicalProcess | cellular detoxification of nitrogen compound | 3.95e-04 | 5 | 131 | 2 | GO:0070458 | |
| GeneOntologyBiologicalProcess | detoxification of nitrogen compound | 3.95e-04 | 5 | 131 | 2 | GO:0051410 | |
| GeneOntologyBiologicalProcess | regulation of dense core granule exocytosis | 3.95e-04 | 5 | 131 | 2 | GO:1905413 | |
| GeneOntologyBiologicalProcess | synapse organization | UNC13B RELN USP9X GRIA1 CAMK1 NEDD4 NLGN3 HMCN2 BAIAP2 BSN CDH8 RAC1 RAC3 | 4.26e-04 | 685 | 131 | 13 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell junction organization | UNC13B RELN USP9X GRIA1 CAMK1 NEDD4 NLGN3 PTPRA HMCN2 BAIAP2 BSN CDH8 CDH13 CDH15 RAC1 RAC3 | 4.58e-04 | 974 | 131 | 16 | GO:0034330 |
| GeneOntologyBiologicalProcess | T cell activation | PDCD1 HLA-DQB2 HLA-DRB1 HLA-DRB4 HLA-DRB5 AP3B1 NEDD4 VNN1 SMARCC2 ADAM17 FGL1 MPZL2 RAC2 | 5.29e-04 | 701 | 131 | 13 | GO:0042110 |
| GeneOntologyBiologicalProcess | protein localization to lysosome | 5.75e-04 | 60 | 131 | 4 | GO:0061462 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | RELN MAP1A USP9X OBSL1 TWF2 TENM2 ATL1 NEDD4 NLGN3 HMCN2 ADAM17 BAIAP2 RAC1 RAC3 | 5.86e-04 | 802 | 131 | 14 | GO:0048812 |
| GeneOntologyBiologicalProcess | erythrocyte enucleation | 5.91e-04 | 6 | 131 | 2 | GO:0043131 | |
| GeneOntologyBiologicalProcess | cytochrome metabolic process | 5.91e-04 | 6 | 131 | 2 | GO:1903604 | |
| GeneOntologyBiologicalProcess | enucleation | 5.91e-04 | 6 | 131 | 2 | GO:0090601 | |
| GeneOntologyBiologicalProcess | enucleate erythrocyte maturation | 5.91e-04 | 6 | 131 | 2 | GO:0043354 | |
| GeneOntologyBiologicalProcess | inhibitory postsynaptic potential | 6.55e-04 | 27 | 131 | 3 | GO:0060080 | |
| GeneOntologyBiologicalProcess | glutathione metabolic process | 6.93e-04 | 63 | 131 | 4 | GO:0006749 | |
| GeneOntologyBiologicalProcess | regulation of T cell activation | PDCD1 HLA-DQB2 HLA-DRB1 HLA-DRB4 HLA-DRB5 AP3B1 VNN1 SMARCC2 FGL1 RAC2 | 6.97e-04 | 458 | 131 | 10 | GO:0050863 |
| GeneOntologyBiologicalProcess | gluconeogenesis | 7.16e-04 | 111 | 131 | 5 | GO:0006094 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | RELN MAP1A USP9X OBSL1 TWF2 TENM2 ATL1 NEDD4 NLGN3 HMCN2 ADAM17 BAIAP2 RAC1 RAC3 | 7.20e-04 | 819 | 131 | 14 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | RELN MAP1A USP9X OBSL1 TWF2 TENM2 ATL1 NEDD4 NLGN3 HMCN2 ADAM17 BAIAP2 RAC1 RAC3 | 7.81e-04 | 826 | 131 | 14 | GO:0048858 |
| GeneOntologyBiologicalProcess | long-chain fatty acid biosynthetic process | 8.11e-04 | 29 | 131 | 3 | GO:0042759 | |
| GeneOntologyBiologicalProcess | axon development | RELN MAP1A USP9X TWF2 TENM2 ATL1 NLGN3 HMCN2 ADAM17 BAIAP2 RAC1 RAC3 | 8.13e-04 | 642 | 131 | 12 | GO:0061564 |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 8.31e-04 | 387 | 131 | 9 | GO:0050807 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 8.41e-04 | 115 | 131 | 5 | GO:0019319 | |
| GeneOntologyBiologicalProcess | protein localization to synapse | 8.41e-04 | 115 | 131 | 5 | GO:0035418 | |
| GeneOntologyBiologicalProcess | intracellular protein transport | RGPD2 RANBP2 RGPD8 MAP1A USP9X RGPD1 CAMK1 AP3B1 NEDD4 RGPD3 SEC16A SORL1 RGPD5 | 8.73e-04 | 740 | 131 | 13 | GO:0006886 |
| GeneOntologyBiologicalProcess | regulation of nervous system process | 8.92e-04 | 175 | 131 | 6 | GO:0031644 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 9.59e-04 | 395 | 131 | 9 | GO:0050803 | |
| GeneOntologyBiologicalProcess | cell junction assembly | 1.03e-03 | 569 | 131 | 11 | GO:0034329 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 1.06e-03 | 121 | 131 | 5 | GO:0046364 | |
| GeneOntologyBiologicalProcess | regulation of cell activation | PDCD1 PDGFRB HLA-DQB2 HLA-DRB1 INPP5D HLA-DRB4 HLA-DRB5 AP3B1 VNN1 GPR137B SMARCC2 FGL1 RAC2 | 1.06e-03 | 756 | 131 | 13 | GO:0050865 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | UNC13B RELN MAP1A GRIA1 GRM1 NEDD4 NLGN3 PTPRA BAIAP2 BSN BAIAP3 RAC1 | 1.07e-03 | 663 | 131 | 12 | GO:0050804 |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 1.08e-03 | 249 | 131 | 7 | GO:0015931 | |
| GeneOntologyBiologicalProcess | positive regulation of lamellipodium assembly | 1.09e-03 | 32 | 131 | 3 | GO:0010592 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | UNC13B RELN MAP1A GRIA1 GRM1 NEDD4 NLGN3 PTPRA BAIAP2 BSN BAIAP3 RAC1 | 1.09e-03 | 664 | 131 | 12 | GO:0099177 |
| GeneOntologyBiologicalProcess | enucleate erythrocyte development | 1.09e-03 | 8 | 131 | 2 | GO:0048822 | |
| GeneOntologyBiologicalProcess | cerebral cortex GABAergic interneuron development | 1.09e-03 | 8 | 131 | 2 | GO:0021894 | |
| GeneOntologyBiologicalProcess | hepoxilin metabolic process | 1.09e-03 | 8 | 131 | 2 | GO:0051121 | |
| GeneOntologyBiologicalProcess | hepoxilin biosynthetic process | 1.09e-03 | 8 | 131 | 2 | GO:0051122 | |
| GeneOntologyBiologicalProcess | leukocyte cell-cell adhesion | PDCD1 HLA-DQB2 HLA-DRB1 HLA-DRB4 HLA-DRB5 AP3B1 VNN1 SMARCC2 FGL1 RAC2 | 1.09e-03 | 486 | 131 | 10 | GO:0007159 |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | 1.19e-03 | 185 | 131 | 6 | GO:0099175 | |
| GeneOntologyBiologicalProcess | protein targeting to lysosome | 1.19e-03 | 33 | 131 | 3 | GO:0006622 | |
| GeneOntologyBiologicalProcess | positive regulation of signaling receptor activity | 1.19e-03 | 33 | 131 | 3 | GO:2000273 | |
| GeneOntologyBiologicalProcess | dendrite development | 1.37e-03 | 335 | 131 | 8 | GO:0016358 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen | 1.40e-03 | 76 | 131 | 4 | GO:0048002 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | RGPD2 RANBP2 RELN RGPD8 PDGFRB ARHGEF5 HLA-DRB1 RGPD1 CAMK1 RGPD3 ADAM17 FAM20A RAC1 | 1.40e-03 | 780 | 131 | 13 | GO:0042327 |
| GeneOntologyBiologicalProcess | monocyte differentiation | 1.41e-03 | 35 | 131 | 3 | GO:0030224 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | RGPD2 RANBP2 RELN RGPD8 PDGFRB ARHGEF5 HLA-DRB1 RGPD1 CAMK1 PPP1R15B RGPD3 ADAM17 FAM20A RAC1 | 1.41e-03 | 879 | 131 | 14 | GO:0045937 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | RGPD2 RANBP2 RELN RGPD8 PDGFRB ARHGEF5 HLA-DRB1 RGPD1 CAMK1 PPP1R15B RGPD3 ADAM17 FAM20A RAC1 | 1.41e-03 | 879 | 131 | 14 | GO:0010562 |
| GeneOntologyBiologicalProcess | actin filament organization | 1.54e-03 | 509 | 131 | 10 | GO:0007015 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 1.55e-03 | 195 | 131 | 6 | GO:0006606 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 1.56e-03 | 132 | 131 | 5 | GO:0043255 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 5.13e-10 | 8 | 132 | 5 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 2.29e-09 | 10 | 132 | 5 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 1.78e-08 | 14 | 132 | 5 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 7.46e-08 | 18 | 132 | 5 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.34e-07 | 20 | 132 | 5 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 1.75e-07 | 21 | 132 | 5 | GO:0106068 | |
| GeneOntologyCellularComponent | trans-Golgi network | SLC9A8 HLA-DQB2 HLA-DRB1 HLA-DRB4 HLA-DRB5 AP3B1 BSN BAIAP3 USP6NL ECE2 RAC1 SORL1 | 5.69e-07 | 306 | 132 | 12 | GO:0005802 |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | SLC9A8 MAN2A1 HLA-DQB2 HLA-DRB1 HLA-DRB4 HLA-DRB5 AP3B1 ATL1 BSN BAIAP3 USP6NL ECE2 RAC1 SORL1 | 8.45e-07 | 443 | 132 | 14 | GO:0098791 |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 2.59e-06 | 35 | 132 | 5 | GO:0098553 | |
| GeneOntologyCellularComponent | transport vesicle membrane | UNC13B HLA-DQB2 HLA-DRB1 HLA-DRB4 HLA-DRB5 GRIA1 SEC16A BSN ECE2 RAC1 SORL1 | 2.62e-06 | 293 | 132 | 11 | GO:0030658 |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 3.14e-06 | 64 | 132 | 6 | GO:0012507 | |
| GeneOntologyCellularComponent | MHC class II protein complex | 3.39e-06 | 17 | 132 | 4 | GO:0042613 | |
| GeneOntologyCellularComponent | NADPH oxidase complex | 4.34e-06 | 18 | 132 | 4 | GO:0043020 | |
| GeneOntologyCellularComponent | trans-Golgi network membrane | 7.13e-06 | 112 | 132 | 7 | GO:0032588 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 1.28e-05 | 48 | 132 | 5 | GO:0098576 | |
| GeneOntologyCellularComponent | MHC protein complex | 2.04e-05 | 26 | 132 | 4 | GO:0042611 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | CYBB RGPD2 RANBP2 RGPD8 HLA-DQB2 CYP3A43 HLA-DRB1 HLA-DRB4 HLA-DRB5 RGPD1 GRIA1 CLCC1 ATL1 RGPD3 SEC16A CYP2U1 ATP11A ALG12 RAC1 RAC2 RAC3 SORL1 | 2.86e-05 | 1327 | 132 | 22 | GO:0042175 |
| GeneOntologyCellularComponent | nuclear pore | 4.39e-05 | 101 | 132 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | Golgi membrane | SLC9A8 MAN2A1 HLA-DQB2 HLA-DRB1 HLA-DRB4 HLA-DRB5 CLCC1 ATL1 MGAT3 SEC16A ADAM17 ARHGAP21 ECE2 RAC1 SORL1 | 5.14e-05 | 721 | 132 | 15 | GO:0000139 |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 7.08e-05 | 110 | 132 | 6 | GO:0030134 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CYBB HLA-DQB2 HLA-DRB1 HLA-DRB4 HLA-DRB5 GRIA1 GRM1 CHRNA2 TRBV5-8 CDH8 CDH13 CDH15 RAC1 RAC2 RAC3 | 1.33e-04 | 785 | 132 | 15 | GO:0098797 |
| GeneOntologyCellularComponent | late endosome membrane | 1.44e-04 | 179 | 132 | 7 | GO:0031902 | |
| GeneOntologyCellularComponent | nuclear envelope | CYBB RGPD2 RANBP2 RGPD8 RGPD1 FAM3B CLCC1 SULT1E1 RGPD3 RAC2 SORL1 RGPD5 | 2.29e-04 | 560 | 132 | 12 | GO:0005635 |
| GeneOntologyCellularComponent | inclusion body | 2.66e-04 | 90 | 132 | 5 | GO:0016234 | |
| GeneOntologyCellularComponent | actin cytoskeleton | ARHGEF5 INPP5D TWF2 RFLNB MICAL2 ADAM17 BAIAP2 ARHGAP21 CNN2 RAC1 RAC2 RAC3 | 2.96e-04 | 576 | 132 | 12 | GO:0015629 |
| GeneOntologyCellularComponent | intercellular bridge | 3.26e-04 | 94 | 132 | 5 | GO:0045171 | |
| GeneOntologyCellularComponent | actin filament | 3.33e-04 | 146 | 132 | 6 | GO:0005884 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 4.04e-04 | 212 | 132 | 7 | GO:0030666 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 4.39e-04 | 215 | 132 | 7 | GO:0030662 | |
| GeneOntologyCellularComponent | anchoring junction | PDGFRB ARHGEF5 OBSL1 GRIA1 TENM2 FCHSD2 PTPRA ADAM17 BAIAP2 CDH8 ARHGAP21 CNN2 CDH13 CDH15 RAC1 RAC2 | 4.42e-04 | 976 | 132 | 16 | GO:0070161 |
| GeneOntologyCellularComponent | transport vesicle | UNC13B HLA-DQB2 HLA-DRB1 HLA-DRB4 HLA-DRB5 GRIA1 SEC16A BSN ECE2 RAC1 SORL1 | 4.61e-04 | 519 | 132 | 11 | GO:0030133 |
| GeneOntologyCellularComponent | axon | UNC13B RELN MAP1A USP9X GARS1 GRIA1 TWF2 GRM1 AP3B1 TENM2 ATL1 HMCN2 BSN CDH8 RAC3 | 5.11e-04 | 891 | 132 | 15 | GO:0030424 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | CYBB UNC13B SLC9A8 HLA-DQB2 HLA-DRB1 HLA-DRB4 HLA-DRB5 GRIA1 AP3B1 VNN1 SEC16A ATP11A BSN BAIAP3 ARHGAP21 ECE2 RAC1 RAC2 SORL1 | 5.61e-04 | 1307 | 132 | 19 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | CYBB UNC13B SLC9A8 HLA-DQB2 HLA-DRB1 HLA-DRB4 HLA-DRB5 GRIA1 AP3B1 VNN1 SEC16A ATP11A BSN BAIAP3 ARHGAP21 ECE2 RAC1 RAC2 SORL1 | 6.62e-04 | 1325 | 132 | 19 | GO:0012506 |
| GeneOntologyCellularComponent | neuron projection cytoplasm | 6.70e-04 | 110 | 132 | 5 | GO:0120111 | |
| GeneOntologyCellularComponent | endocytic vesicle | CYBB UNC13B HLA-DQB2 HLA-DRB1 HLA-DRB4 HLA-DRB5 GRIA1 NLGN3 RAC2 | 7.56e-04 | 384 | 132 | 9 | GO:0030139 |
| GeneOntologyCellularComponent | catenin complex | 1.07e-03 | 32 | 132 | 3 | GO:0016342 | |
| GeneOntologyCellularComponent | synaptic membrane | UNC13B GRIA1 GRM1 TENM2 CHRNA2 NLGN3 PTPRA BAIAP2 BSN CDH8 RAC1 | 1.19e-03 | 583 | 132 | 11 | GO:0097060 |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle membrane | 1.58e-03 | 79 | 132 | 4 | GO:0030669 | |
| GeneOntologyCellularComponent | glutamatergic synapse | UNC13B GRIA1 CAMK1 GRM1 TENM2 TRIM3 NEDD4 NLGN3 BAIAP2 BSN CDH8 RAC1 RAC3 | 2.01e-03 | 817 | 132 | 13 | GO:0098978 |
| GeneOntologyCellularComponent | cytoplasmic region | 2.07e-03 | 360 | 132 | 8 | GO:0099568 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 2.43e-03 | 147 | 132 | 5 | GO:0030665 | |
| GeneOntologyCellularComponent | recycling endosome | 2.89e-03 | 222 | 132 | 6 | GO:0055037 | |
| GeneOntologyCellularComponent | dendrite | CYBB RELN MAP1A GLRX3 GRIA1 GRM1 TENM2 TRIM3 NEDD4 NLGN3 BAIAP2 BSN RAC1 | 3.07e-03 | 858 | 132 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CYBB RELN MAP1A GLRX3 GRIA1 GRM1 TENM2 TRIM3 NEDD4 NLGN3 BAIAP2 BSN RAC1 | 3.14e-03 | 860 | 132 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | CYBB HLA-DQB2 CYP3A43 HLA-DRB1 HLA-DRB4 HLA-DRB5 GRIA1 CLCC1 ATL1 SEC16A CYP2U1 ATP11A ALG12 RAC1 RAC2 RAC3 SORL1 | 3.22e-03 | 1293 | 132 | 17 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | CYBB HLA-DQB2 CYP3A43 HLA-DRB1 HLA-DRB4 HLA-DRB5 GRIA1 CLCC1 ATL1 SEC16A CYP2U1 ATP11A ALG12 RAC1 RAC2 RAC3 SORL1 | 3.38e-03 | 1299 | 132 | 17 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear envelope lumen | 3.43e-03 | 14 | 132 | 2 | GO:0005641 | |
| GeneOntologyCellularComponent | lamellipodium | 3.44e-03 | 230 | 132 | 6 | GO:0030027 | |
| GeneOntologyCellularComponent | oxidoreductase complex | 3.59e-03 | 161 | 132 | 5 | GO:1990204 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle | 3.87e-03 | 101 | 132 | 4 | GO:0045334 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 3.89e-03 | 164 | 132 | 5 | GO:0098982 | |
| GeneOntologyCellularComponent | tertiary granule | 3.89e-03 | 164 | 132 | 5 | GO:0070820 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 4.05e-03 | 317 | 132 | 7 | GO:0032838 | |
| GeneOntologyCellularComponent | dendritic spine | 4.41e-03 | 242 | 132 | 6 | GO:0043197 | |
| GeneOntologyCellularComponent | cell leading edge | 4.52e-03 | 500 | 132 | 9 | GO:0031252 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CYBB RELN MAP1A GLRX3 GRIA1 GRM1 TENM2 TRIM3 NEDD4 NLGN3 HMCN2 BAIAP2 BSN RAC1 RAC3 SORL1 | 4.65e-03 | 1228 | 132 | 16 | GO:0036477 |
| GeneOntologyCellularComponent | excitatory synapse | 4.75e-03 | 107 | 132 | 4 | GO:0060076 | |
| GeneOntologyCellularComponent | neuron spine | 4.87e-03 | 247 | 132 | 6 | GO:0044309 | |
| GeneOntologyCellularComponent | iron-sulfur cluster assembly complex | 5.06e-03 | 17 | 132 | 2 | GO:1990229 | |
| GeneOntologyCellularComponent | postsynapse | MAP1A USP9X GRIA1 CAMK1 GRM1 TENM2 CHRNA2 TRIM3 NEDD4 NLGN3 BAIAP2 BSN RAC1 RAC3 | 5.06e-03 | 1018 | 132 | 14 | GO:0098794 |
| GeneOntologyCellularComponent | neuromuscular junction | 5.58e-03 | 112 | 132 | 4 | GO:0031594 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 5.58e-03 | 112 | 132 | 4 | GO:0055038 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | CYBB RGPD2 RANBP2 RGPD8 RGPD1 OBSL1 TWF2 NEDD4 RGPD3 SEC16A CDH13 RAC3 SORL1 | 6.23e-03 | 934 | 132 | 13 | GO:0048471 |
| GeneOntologyCellularComponent | membrane protein complex | CYBB HLA-DQB2 HLA-DRB1 HLA-DRB4 HLA-DRB5 GRIA1 GRM1 AP3B1 BCS1L CHRNA2 CLCC1 TRBV5-8 CDH8 CDH13 CDH15 RAC1 RAC2 RAC3 | 6.23e-03 | 1498 | 132 | 18 | GO:0098796 |
| GeneOntologyCellularComponent | late endosome | 6.68e-03 | 348 | 132 | 7 | GO:0005770 | |
| GeneOntologyCellularComponent | nuclear membrane | 6.78e-03 | 349 | 132 | 7 | GO:0031965 | |
| GeneOntologyCellularComponent | coated vesicle | 7.98e-03 | 360 | 132 | 7 | GO:0030135 | |
| GeneOntologyCellularComponent | lysosomal membrane | HLA-DQB2 HLA-DRB1 HLA-DRB4 HLA-DRB5 AP3B1 VNN1 GPR137B ATP11A | 9.12e-03 | 462 | 132 | 8 | GO:0005765 |
| GeneOntologyCellularComponent | lytic vacuole membrane | HLA-DQB2 HLA-DRB1 HLA-DRB4 HLA-DRB5 AP3B1 VNN1 GPR137B ATP11A | 9.12e-03 | 462 | 132 | 8 | GO:0098852 |
| GeneOntologyCellularComponent | axon cytoplasm | 9.15e-03 | 68 | 132 | 3 | GO:1904115 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 9.18e-03 | 23 | 132 | 2 | GO:0098831 | |
| GeneOntologyCellularComponent | cell cortex | 9.32e-03 | 371 | 132 | 7 | GO:0005938 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 1.12e-07 | 16 | 110 | 5 | MP:0003701 | |
| MousePheno | abnormal morula morphology | 1.59e-06 | 26 | 110 | 5 | MP:0012058 | |
| MousePheno | decreased tumor latency | 3.35e-06 | 30 | 110 | 5 | MP:0010308 | |
| MousePheno | failure of blastocyst formation | 3.97e-06 | 31 | 110 | 5 | MP:0012129 | |
| MousePheno | abnormal tumor latency | 6.39e-06 | 34 | 110 | 5 | MP:0010307 | |
| MousePheno | enlarged epididymis | 1.27e-05 | 99 | 110 | 7 | MP:0004931 | |
| MousePheno | abnormal blastocyst formation | 1.28e-05 | 39 | 110 | 5 | MP:0012128 | |
| MousePheno | abnormal rod electrophysiology | 4.19e-05 | 119 | 110 | 7 | MP:0004021 | |
| MousePheno | abnormal epididymis size | 4.90e-05 | 166 | 110 | 8 | MP:0004926 | |
| MousePheno | abnormal chromosome morphology | 6.03e-05 | 126 | 110 | 7 | MP:0003702 | |
| MousePheno | abnormal upper incisor color | 6.14e-05 | 2 | 110 | 2 | MP:0030139 | |
| MousePheno | abnormal cell nucleus morphology | 1.01e-04 | 184 | 110 | 8 | MP:0003111 | |
| MousePheno | aneuploidy | 1.15e-04 | 61 | 110 | 5 | MP:0004024 | |
| MousePheno | abnormal locomotor coordination | RELN MAP1A GARS1 GRIA1 GRM1 CMAS CLCC1 ATL1 NEDD4 UHRF1 MPZL2 BSN ANKFN1 RAC3 FOXI1 SORL1 | 1.71e-04 | 726 | 110 | 16 | MP:0003312 |
| MousePheno | increased CNS synapse formation | 1.83e-04 | 3 | 110 | 2 | MP:0004997 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 1.96e-04 | 107 | 110 | 6 | MP:0003694 | |
| MousePheno | embryonic lethality before implantation, complete penetrance | 1.99e-04 | 203 | 110 | 8 | MP:0011094 | |
| MousePheno | increased hepatocellular carcinoma incidence | 2.22e-04 | 70 | 110 | 5 | MP:0003331 | |
| MousePheno | abnormal blastocyst hatching | 2.64e-04 | 113 | 110 | 6 | MP:0003693 | |
| MousePheno | abnormal lower incisor color | 3.64e-04 | 4 | 110 | 2 | MP:0030138 | |
| MousePheno | increased lung carcinoma incidence | 3.68e-04 | 78 | 110 | 5 | MP:0008714 | |
| MousePheno | abnormal eye electrophysiology | 4.35e-04 | 228 | 110 | 8 | MP:0005551 | |
| Domain | Ran_BP1 | 9.47e-11 | 12 | 131 | 6 | PF00638 | |
| Domain | RANBD1 | 9.47e-11 | 12 | 131 | 6 | PS50196 | |
| Domain | RanBD | 1.75e-10 | 13 | 131 | 6 | SM00160 | |
| Domain | Ran_bind_dom | 1.75e-10 | 13 | 131 | 6 | IPR000156 | |
| Domain | Grip | 7.02e-09 | 11 | 131 | 5 | SM00755 | |
| Domain | GRIP | 7.02e-09 | 11 | 131 | 5 | PF01465 | |
| Domain | GST_mu | 1.15e-08 | 5 | 131 | 4 | IPR003081 | |
| Domain | GRIP_dom | 1.20e-08 | 12 | 131 | 5 | IPR000237 | |
| Domain | GRIP | 1.20e-08 | 12 | 131 | 5 | PS50913 | |
| Domain | Rab_bind | 7.96e-08 | 7 | 131 | 4 | PF16704 | |
| Domain | GCC2_Rab_bind | 7.96e-08 | 7 | 131 | 4 | IPR032023 | |
| Domain | MHC_II_b_N | 1.58e-07 | 8 | 131 | 4 | PD000328 | |
| Domain | MHC_II_b_N | 2.83e-07 | 9 | 131 | 4 | IPR000353 | |
| Domain | MHC_II_beta | 2.83e-07 | 9 | 131 | 4 | SM00921 | |
| Domain | MHC_II_beta | 2.83e-07 | 9 | 131 | 4 | PF00969 | |
| Domain | - | 4.70e-07 | 10 | 131 | 4 | 1.10.220.60 | |
| Domain | MHC_II_a/b_N | 2.19e-06 | 14 | 131 | 4 | IPR014745 | |
| Domain | - | 2.19e-06 | 14 | 131 | 4 | 3.10.320.10 | |
| Domain | GST_N | 1.53e-05 | 22 | 131 | 4 | PF02798 | |
| Domain | GST_NTER | 1.53e-05 | 22 | 131 | 4 | PS50404 | |
| Domain | GST_C | 3.07e-05 | 26 | 131 | 4 | IPR004046 | |
| Domain | GST_C | 3.07e-05 | 26 | 131 | 4 | PF00043 | |
| Domain | Glutathione_S-Trfase_N | 3.58e-05 | 27 | 131 | 4 | IPR004045 | |
| Domain | ARHGEF5_35 | 4.88e-05 | 2 | 131 | 2 | PF15441 | |
| Domain | ARHGEF5/35_N | 4.88e-05 | 2 | 131 | 2 | IPR029212 | |
| Domain | GST_CTER | 9.11e-05 | 34 | 131 | 4 | PS50405 | |
| Domain | MHC_I/II-like_Ag-recog | 1.42e-04 | 38 | 131 | 4 | IPR011162 | |
| Domain | Glutathione-S-Trfase_C-like | 1.57e-04 | 39 | 131 | 4 | IPR010987 | |
| Domain | - | 1.57e-04 | 39 | 131 | 4 | 1.20.1050.10 | |
| Domain | RHO | 3.52e-04 | 20 | 131 | 3 | PS51420 | |
| Domain | Munc13_dom-2 | 4.82e-04 | 5 | 131 | 2 | IPR014772 | |
| Domain | MHD2 | 4.82e-04 | 5 | 131 | 2 | PS51259 | |
| Domain | Munc13_subgr_dom-2 | 4.82e-04 | 5 | 131 | 2 | IPR019558 | |
| Domain | Membr_traf_MHD | 4.82e-04 | 5 | 131 | 2 | PF10540 | |
| Domain | C1-set | 5.57e-04 | 54 | 131 | 4 | PF07654 | |
| Domain | IGc1 | 6.40e-04 | 56 | 131 | 4 | SM00407 | |
| Domain | TPR-contain_dom | 6.65e-04 | 150 | 131 | 6 | IPR013026 | |
| Domain | Ig/MHC_CS | 7.32e-04 | 58 | 131 | 4 | IPR003006 | |
| Domain | Ig_C1-set | 7.32e-04 | 58 | 131 | 4 | IPR003597 | |
| Domain | IG_MHC | 8.32e-04 | 60 | 131 | 4 | PS00290 | |
| Domain | Munc13_1 | 1.00e-03 | 7 | 131 | 2 | IPR014770 | |
| Domain | MHD1 | 1.00e-03 | 7 | 131 | 2 | PS51258 | |
| Domain | DUF1041 | 1.00e-03 | 7 | 131 | 2 | PF06292 | |
| Domain | CAPS_dom | 1.00e-03 | 7 | 131 | 2 | IPR010439 | |
| Domain | TPR_REGION | 1.09e-03 | 165 | 131 | 6 | PS50293 | |
| Domain | TPR | 1.09e-03 | 165 | 131 | 6 | PS50005 | |
| Domain | TPR-like_helical_dom | 1.30e-03 | 233 | 131 | 7 | IPR011990 | |
| Domain | Ig-like_fold | PDCD1 PDGFRB HLA-DQB2 HLA-DRB1 HLA-DRB4 HLA-DRB5 OBSL1 TRIM3 HMCN2 MPZL2 ANKFN1 ALPK2 SORL1 | 1.39e-03 | 706 | 131 | 13 | IPR013783 |
| Domain | - | 1.69e-03 | 122 | 131 | 5 | 3.40.30.10 | |
| Domain | Sialidases | 1.70e-03 | 9 | 131 | 2 | IPR011040 | |
| Domain | GST_C_3 | 2.12e-03 | 10 | 131 | 2 | PF14497 | |
| Domain | TPR | 2.16e-03 | 129 | 131 | 5 | SM00028 | |
| Domain | MYB_LIKE | 2.38e-03 | 38 | 131 | 3 | PS50090 | |
| Domain | Thioredoxin-like_fold | 2.39e-03 | 132 | 131 | 5 | IPR012336 | |
| Domain | IG_LIKE | PDCD1 PDGFRB HLA-DQB2 HLA-DRB1 HLA-DRB4 HLA-DRB5 OBSL1 HMCN2 MPZL2 ALPK2 | 2.44e-03 | 491 | 131 | 10 | PS50835 |
| Domain | - | PDCD1 PDGFRB HLA-DQB2 HLA-DRB1 HLA-DRB4 HLA-DRB5 OBSL1 TRIM3 MPZL2 ANKFN1 ALPK2 SORL1 | 2.45e-03 | 663 | 131 | 12 | 2.60.40.10 |
| Domain | TPR_repeat | 2.47e-03 | 133 | 131 | 5 | IPR019734 | |
| Domain | - | 2.56e-03 | 39 | 131 | 3 | 2.120.10.30 | |
| Domain | Ig-like_dom | PDCD1 PDGFRB HLA-DQB2 HLA-DRB1 HLA-DRB4 HLA-DRB5 OBSL1 HMCN2 MPZL2 ALPK2 | 2.90e-03 | 503 | 131 | 10 | IPR007110 |
| Domain | PH_dom-like | RGPD2 RANBP2 RGPD8 ARHGEF5 RGPD1 PLEKHA6 RGPD3 ARHGAP21 RGPD5 | 3.14e-03 | 426 | 131 | 9 | IPR011993 |
| Domain | NHL | 3.62e-03 | 13 | 131 | 2 | PS51125 | |
| Domain | TPR_1 | 3.71e-03 | 90 | 131 | 4 | IPR001440 | |
| Domain | TPR_1 | 3.71e-03 | 90 | 131 | 4 | PF00515 | |
| Domain | 6-blade_b-propeller_TolB-like | 4.11e-03 | 46 | 131 | 3 | IPR011042 | |
| Domain | SANT/Myb | 5.80e-03 | 52 | 131 | 3 | IPR001005 | |
| Domain | - | 6.37e-03 | 391 | 131 | 8 | 2.30.29.30 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 1.73e-07 | 18 | 106 | 5 | MM1549 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 7.62e-07 | 43 | 106 | 6 | MM14609 | |
| Pathway | REACTOME_PD_1_SIGNALING | 1.87e-06 | 28 | 106 | 5 | M18810 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.90e-06 | 50 | 106 | 6 | MM14610 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_DCE_TO_DNA_ADDUCTS | 1.07e-05 | 19 | 106 | 4 | M47809 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.17e-05 | 40 | 106 | 5 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.32e-05 | 41 | 106 | 5 | MM15200 | |
| Pathway | REACTOME_PD_1_SIGNALING | 1.33e-05 | 20 | 106 | 4 | MM15001 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 1.39e-05 | 70 | 106 | 6 | M12294 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GH_TO_ITGA_B_RHOA_SIGNALING_PATHWAY | 1.42e-05 | 7 | 106 | 3 | M47538 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.49e-05 | 42 | 106 | 5 | MM15039 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 1.92e-05 | 74 | 106 | 6 | M17386 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_TCDD_TO_AHR_SIGNALING_PATHWAY | 2.40e-05 | 23 | 106 | 4 | M47806 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 2.61e-05 | 47 | 106 | 5 | MM14939 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KEAP1_NRF2_SIGNALING_PATHWAY | 2.86e-05 | 24 | 106 | 4 | M47487 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 3.20e-05 | 49 | 106 | 5 | MM14837 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 3.90e-05 | 51 | 106 | 5 | MM15151 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 4.53e-05 | 86 | 106 | 6 | MM15413 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGG_FCGR_RAC_SIGNALING_PATHWAY | 4.77e-05 | 10 | 106 | 3 | M47727 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 5.64e-05 | 55 | 106 | 5 | MM14917 | |
| Pathway | BIOCARTA_BBCELL_PATHWAY | 6.53e-05 | 11 | 106 | 3 | M22030 | |
| Pathway | BIOCARTA_EOSINOPHILS_PATHWAY | 6.53e-05 | 11 | 106 | 3 | M22048 | |
| Pathway | WP_OXIDATIVE_STRESS_AND_REDOX_PATHWAY | 6.62e-05 | 92 | 106 | 6 | MM15823 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 7.06e-05 | 183 | 106 | 8 | M39588 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 7.30e-05 | 58 | 106 | 5 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 7.30e-05 | 58 | 106 | 5 | MM14736 | |
| Pathway | WP_RALA_DOWNSTREAM_REGULATED_GENES | 8.65e-05 | 12 | 106 | 3 | M39408 | |
| Pathway | BIOCARTA_IL5_PATHWAY | 1.12e-04 | 13 | 106 | 3 | M18928 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 1.26e-04 | 65 | 106 | 5 | MM15147 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 1.36e-04 | 66 | 106 | 5 | MM14990 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 1.36e-04 | 257 | 106 | 9 | MM14755 | |
| Pathway | BIOCARTA_MHC_PATHWAY | 1.42e-04 | 14 | 106 | 3 | M22023 | |
| Pathway | BIOCARTA_TCRA_PATHWAY | 1.42e-04 | 14 | 106 | 3 | M10765 | |
| Pathway | BIOCARTA_BLYMPHOCYTE_PATHWAY | 1.42e-04 | 14 | 106 | 3 | M1473 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 1.48e-04 | 36 | 106 | 4 | M1443 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_NFY_MEDIATED_TRANSCRIPTION | 1.76e-04 | 15 | 106 | 3 | M47588 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_II_MOLECULES | 1.76e-04 | 15 | 106 | 3 | M47604 | |
| Pathway | BIOCARTA_ASBCELL_PATHWAY | 1.76e-04 | 15 | 106 | 3 | M7298 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 1.79e-04 | 70 | 106 | 5 | M16794 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 1.83e-04 | 38 | 106 | 4 | MM14600 | |
| Pathway | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | 2.03e-04 | 39 | 106 | 4 | M16523 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 2.05e-04 | 72 | 106 | 5 | M9257 | |
| Pathway | REACTOME_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE | 2.16e-04 | 16 | 106 | 3 | MM14808 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 2.19e-04 | 73 | 106 | 5 | MM14948 | |
| Pathway | WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY | 2.24e-04 | 40 | 106 | 4 | M39695 | |
| Pathway | REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS | 3.67e-04 | 19 | 106 | 3 | MM14807 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 3.77e-04 | 82 | 106 | 5 | MM15394 | |
| Pathway | WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY | 3.87e-04 | 46 | 106 | 4 | MM15837 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 4.21e-04 | 84 | 106 | 5 | MM14929 | |
| Pathway | WP_EBOLA_VIRUS_INFECTION_IN_HOST | 4.22e-04 | 129 | 106 | 6 | M39693 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 4.97e-04 | 133 | 106 | 6 | M16476 | |
| Pathway | KEGG_GLUTATHIONE_METABOLISM | 5.33e-04 | 50 | 106 | 4 | M1840 | |
| Pathway | BIOCARTA_CSK_PATHWAY | 5.74e-04 | 22 | 106 | 3 | M6327 | |
| Pathway | BIOCARTA_CTLA4_PATHWAY | 5.74e-04 | 22 | 106 | 3 | M1467 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 6.40e-04 | 92 | 106 | 5 | MM14951 | |
| Pathway | BIOCARTA_TH1TH2_PATHWAY | 6.56e-04 | 23 | 106 | 3 | M6705 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 6.76e-04 | 141 | 106 | 6 | MM15266 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES | 7.46e-04 | 24 | 106 | 3 | M27553 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES | 8.43e-04 | 25 | 106 | 3 | MM15269 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 8.53e-04 | 98 | 106 | 5 | M39830 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 8.53e-04 | 98 | 106 | 5 | M965 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 9.35e-04 | 100 | 106 | 5 | MM14561 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY | 9.47e-04 | 26 | 106 | 3 | M47561 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY | 9.47e-04 | 26 | 106 | 3 | M47562 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 1.04e-03 | 153 | 106 | 6 | MM15844 | |
| Pathway | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | 1.06e-03 | 27 | 106 | 3 | MM14809 | |
| Pathway | WP_GLUTATHIONE_METABOLISM | 1.06e-03 | 27 | 106 | 3 | MM15908 | |
| Pathway | REACTOME_AZATHIOPRINE_ADME | 1.06e-03 | 27 | 106 | 3 | MM15693 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | CYBB RGPD2 RANBP2 RGPD8 USP9X ARHGEF5 RGPD1 RGPD3 BAIAP2 ARHGAP21 RAC1 RAC2 RAC3 | 1.14e-03 | 649 | 106 | 13 | MM15690 |
| Pathway | REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS | 1.15e-03 | 7 | 106 | 2 | M27947 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 1.18e-03 | 28 | 106 | 3 | M47655 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.27e-03 | 107 | 106 | 5 | MM14595 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRNP_PI3K_NOX2_SIGNALING_PATHWAY | 1.31e-03 | 29 | 106 | 3 | M47764 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 1.31e-03 | 29 | 106 | 3 | M6910 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.32e-03 | 219 | 106 | 7 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.35e-03 | 220 | 106 | 7 | M10320 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.37e-03 | 109 | 106 | 5 | M18788 | |
| Pathway | KEGG_ASTHMA | 1.45e-03 | 30 | 106 | 3 | M13950 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 1.45e-03 | 30 | 106 | 3 | M47718 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 1.68e-03 | 114 | 106 | 5 | MM15361 | |
| Pathway | REACTOME_SUMOYLATION | 1.72e-03 | 169 | 106 | 6 | MM14919 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 1.88e-03 | 117 | 106 | 5 | MM15387 | |
| Pathway | REACTOME_DRUG_ADME | 2.03e-03 | 119 | 106 | 5 | MM15692 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 2.21e-03 | 73 | 106 | 4 | M638 | |
| Pathway | REACTOME_TCR_SIGNALING | 2.43e-03 | 124 | 106 | 5 | M15381 | |
| Pathway | KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY | 2.44e-03 | 75 | 106 | 4 | M5436 | |
| Pathway | KEGG_ALLOGRAFT_REJECTION | 2.67e-03 | 37 | 106 | 3 | M18615 | |
| Pathway | WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE | 2.67e-03 | 37 | 106 | 3 | M45513 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 2.88e-03 | 129 | 106 | 5 | MM14894 | |
| Pathway | KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY | 2.94e-03 | 79 | 106 | 4 | M11816 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 3.10e-03 | 39 | 106 | 3 | MM15695 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 3.34e-03 | 40 | 106 | 3 | MM15060 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 3.52e-03 | 12 | 106 | 2 | M27128 | |
| Pathway | KEGG_GRAFT_VERSUS_HOST_DISEASE | 3.58e-03 | 41 | 106 | 3 | M13519 | |
| Pubmed | 1.64e-11 | 7 | 134 | 5 | 9037092 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.64e-11 | 7 | 134 | 5 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 1.64e-11 | 7 | 134 | 5 | 11353387 | |
| Pubmed | 1.64e-11 | 7 | 134 | 5 | 30944974 | ||
| Pubmed | 1.64e-11 | 7 | 134 | 5 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 1.64e-11 | 7 | 134 | 5 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 1.64e-11 | 7 | 134 | 5 | 17372272 | |
| Pubmed | 1.64e-11 | 7 | 134 | 5 | 38657106 | ||
| Pubmed | 1.64e-11 | 7 | 134 | 5 | 21205196 | ||
| Pubmed | 1.64e-11 | 7 | 134 | 5 | 18949001 | ||
| Pubmed | 1.64e-11 | 7 | 134 | 5 | 25187515 | ||
| Pubmed | 1.64e-11 | 7 | 134 | 5 | 8603673 | ||
| Pubmed | 1.64e-11 | 7 | 134 | 5 | 26632511 | ||
| Pubmed | 1.64e-11 | 7 | 134 | 5 | 24403063 | ||
| Pubmed | 1.64e-11 | 7 | 134 | 5 | 23818861 | ||
| Pubmed | 1.64e-11 | 7 | 134 | 5 | 23536549 | ||
| Pubmed | 1.64e-11 | 7 | 134 | 5 | 12191015 | ||
| Pubmed | 1.64e-11 | 7 | 134 | 5 | 22821000 | ||
| Pubmed | 1.64e-11 | 7 | 134 | 5 | 20682751 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 4.37e-11 | 8 | 134 | 5 | 21670213 | |
| Pubmed | 4.37e-11 | 8 | 134 | 5 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 4.37e-11 | 8 | 134 | 5 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 4.37e-11 | 8 | 134 | 5 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 4.37e-11 | 8 | 134 | 5 | 28745977 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 9.80e-11 | 9 | 134 | 5 | 18394993 | |
| Pubmed | 9.80e-11 | 9 | 134 | 5 | 28100513 | ||
| Pubmed | 9.80e-11 | 9 | 134 | 5 | 17887960 | ||
| Pubmed | 9.80e-11 | 9 | 134 | 5 | 11553612 | ||
| Pubmed | 9.80e-11 | 9 | 134 | 5 | 10601307 | ||
| Pubmed | 9.80e-11 | 9 | 134 | 5 | 9733766 | ||
| Pubmed | 9.80e-11 | 9 | 134 | 5 | 28877029 | ||
| Pubmed | 1.95e-10 | 10 | 134 | 5 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 1.95e-10 | 10 | 134 | 5 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 1.95e-10 | 10 | 134 | 5 | 8857542 | |
| Pubmed | 1.95e-10 | 10 | 134 | 5 | 21859863 | ||
| Pubmed | 3.57e-10 | 11 | 134 | 5 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 3.57e-10 | 11 | 134 | 5 | 35771867 | |
| Pubmed | 3.57e-10 | 11 | 134 | 5 | 34110283 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 9.89e-10 | 13 | 134 | 5 | 31427429 | |
| Pubmed | 1.05e-09 | 5 | 134 | 4 | 18551009 | ||
| Pubmed | 1.05e-09 | 5 | 134 | 4 | 19856098 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | RGPD2 RANBP2 RGPD8 MAP1A RGPD1 PLEKHA6 TRIM3 NEDD4 RGPD3 SMARCC2 BSN | 1.76e-09 | 231 | 134 | 11 | 16452087 |
| Pubmed | 2.29e-09 | 15 | 134 | 5 | 14697343 | ||
| Pubmed | RGPD2 RANBP2 RGPD8 USP9X RGPD1 GRIA1 GRM1 TENM2 TRIM3 NEDD4 NLGN3 RGPD3 NAT10 SEC16A SMARCC2 BAIAP2 BSN ARHGAP21 RAC1 | 5.95e-09 | 963 | 134 | 19 | 28671696 | |
| Pubmed | MAP1A USP9X GRIA1 TWF2 PLEKHA6 GRM1 AP3B1 CMAS TRIM3 GSTM1 NLGN3 FASN SAFB MGAT3 PTPRA MICAL2 SEC16A PACS2 SMARCC2 BAIAP2 BSN ARHGAP21 RAC1 | 6.21e-09 | 1431 | 134 | 23 | 37142655 | |
| Pubmed | 7.31e-09 | 7 | 134 | 4 | 1905983 | ||
| Pubmed | Role of the Rho GTPase Rac in the activation of the phagocyte NADPH oxidase: outsourcing a key task. | 1.46e-08 | 8 | 134 | 4 | 24598074 | |
| Pubmed | 1.46e-08 | 8 | 134 | 4 | 27048830 | ||
| Pubmed | 1.97e-08 | 22 | 134 | 5 | 27717094 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 16081809 | ||
| Pubmed | Signaling and cytoskeletal requirements in erythroblast enucleation. | 5.59e-08 | 3 | 134 | 3 | 22461493 | |
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 6434690 | ||
| Pubmed | Small Extracellular Vesicles Have GST Activity and Ameliorate Senescence-Related Tissue Damage. | 5.59e-08 | 3 | 134 | 3 | 32574561 | |
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 9452477 | ||
| Pubmed | Recent origin of HLA-DRB1 alleles and implications for human evolution. | 5.59e-08 | 3 | 134 | 3 | 9500545 | |
| Pubmed | Mice with double knockout of H2-Eb1 and H2-Ab1 exhibit reduced susceptibility to allergic rhinitis. | 5.59e-08 | 3 | 134 | 3 | 30372475 | |
| Pubmed | A novel DRB1*09 allelic sequence in the Jing ethnic minority of China. | 5.59e-08 | 3 | 134 | 3 | 12121280 | |
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 19811438 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 3099214 | ||
| Pubmed | rac, a novel ras-related family of proteins that are botulinum toxin substrates. | 5.59e-08 | 3 | 134 | 3 | 2674130 | |
| Pubmed | A novel HLA-DRB1*09 allele, HLA-DRB1*090103*, isolated from the Han population of Guangdong, China. | 5.59e-08 | 3 | 134 | 3 | 15730527 | |
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 20193583 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 22123845 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 16549767 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 16441501 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 6086309 | ||
| Pubmed | Complete cDNA sequences of the HLA-DRB1*0402 and DRB1*11041 alleles. | 5.59e-08 | 3 | 134 | 3 | 12358860 | |
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 8471052 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 1428007 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 7652736 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 20833718 | ||
| Pubmed | Allelic diversity is generated by intraexon sequence exchange at the DRB1 locus of primates. | 5.59e-08 | 3 | 134 | 3 | 2023919 | |
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 6436017 | ||
| Pubmed | Shared class II MHC polymorphisms between humans and chimpanzees. | 5.59e-08 | 3 | 134 | 3 | 2511168 | |
| Pubmed | Nucleotide sequence analysis of class II genes borne by mouse t chromosomes. | 5.59e-08 | 3 | 134 | 3 | 3692165 | |
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 34943902 | ||
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 1.52e-07 | 153 | 134 | 8 | 26365490 | |
| Pubmed | HLA class II antigens and the HIV envelope glycoprotein gp120 bind to the same face of CD4. | 2.05e-07 | 14 | 134 | 4 | 7512597 | |
| Pubmed | Interaction of CD4 with HLA class II antigens and HIV gp120. | 2.05e-07 | 14 | 134 | 4 | 1869305 | |
| Pubmed | Allelic variation in the DR subregion of the human major histocompatibility complex. | 2.23e-07 | 4 | 134 | 3 | 3476943 | |
| Pubmed | Identification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13. | 2.23e-07 | 4 | 134 | 3 | 8317488 | |
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 26740600 | ||
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 22406107 | ||
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 8373352 | ||
| Pubmed | Analysis of DR beta and DQ beta chain cDNA clones from a DR7 haplotype. | 2.23e-07 | 4 | 134 | 3 | 3020127 | |
| Pubmed | HLA-DRB alleles and systemic lupus erythematosus in Jamaicans. | 2.23e-07 | 4 | 134 | 3 | 12144077 | |
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 18520346 | ||
| Pubmed | Variation in the GST mu locus and tobacco smoke exposure as determinants of childhood lung function. | 2.23e-07 | 4 | 134 | 3 | 19151192 | |
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 9480752 | ||
| Pubmed | Strategy for identifying dendritic cell-processed CD4+ T cell epitopes from the HIV gag p24 protein. | 2.78e-07 | 15 | 134 | 4 | 22860026 | |
| Pubmed | 2.78e-07 | 15 | 134 | 4 | 9079699 | ||
| Pubmed | 2.78e-07 | 15 | 134 | 4 | 8376762 | ||
| Pubmed | 2.78e-07 | 15 | 134 | 4 | 8168144 | ||
| Pubmed | 2.78e-07 | 15 | 134 | 4 | 7602119 | ||
| Pubmed | 2.78e-07 | 15 | 134 | 4 | 1967269 | ||
| Pubmed | 2.78e-07 | 15 | 134 | 4 | 3489470 | ||
| Pubmed | 2.78e-07 | 15 | 134 | 4 | 10729169 | ||
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 3.57e-07 | 38 | 134 | 5 | 12791264 | |
| Pubmed | Inhibition of CD4+ T cell function by the HIV envelope protein, gp120. | 3.70e-07 | 16 | 134 | 4 | 2846691 | |
| Pubmed | Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. | 3.70e-07 | 16 | 134 | 4 | 2543930 | |
| Interaction | RGPD4 interactions | 4.61e-09 | 22 | 131 | 6 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 1.78e-08 | 27 | 131 | 6 | int:RGPD2 | |
| Interaction | RGPD3 interactions | 5.80e-07 | 47 | 131 | 6 | int:RGPD3 | |
| Interaction | RGPD1 interactions | 7.48e-07 | 49 | 131 | 6 | int:RGPD1 | |
| Interaction | GSTM5 interactions | 2.20e-06 | 15 | 131 | 4 | int:GSTM5 | |
| Interaction | CTNNA1 interactions | GARS1 OBSL1 PLEKHA6 CEP350 FASN PHACTR4 CDH8 ARHGAP21 CDH15 RAC1 RAC2 RAC3 | 2.85e-06 | 347 | 131 | 12 | int:CTNNA1 |
| Interaction | RGPD5 interactions | 3.08e-06 | 96 | 131 | 7 | int:RGPD5 | |
| Interaction | NPIPB6 interactions | 4.86e-06 | 18 | 131 | 4 | int:NPIPB6 | |
| Interaction | RGPD8 interactions | 8.67e-06 | 74 | 131 | 6 | int:RGPD8 | |
| Interaction | GSTM2 interactions | 1.14e-05 | 22 | 131 | 4 | int:GSTM2 | |
| Interaction | FHOD1 interactions | 1.36e-05 | 80 | 131 | 6 | int:FHOD1 | |
| Interaction | ARHGEF35 interactions | 2.19e-05 | 9 | 131 | 3 | int:ARHGEF35 | |
| Interaction | B2M interactions | 3.03e-05 | 92 | 131 | 6 | int:B2M | |
| Interaction | EPS8 interactions | 3.04e-05 | 136 | 131 | 7 | int:EPS8 | |
| Interaction | RCC1 interactions | 5.17e-05 | 201 | 131 | 8 | int:RCC1 | |
| Interaction | PLCB4 interactions | 5.32e-05 | 32 | 131 | 4 | int:PLCB4 | |
| Interaction | AGAP2 interactions | 7.03e-05 | 210 | 131 | 8 | int:AGAP2 | |
| Interaction | DNAAF1 interactions | 7.32e-05 | 13 | 131 | 3 | int:DNAAF1 | |
| Interaction | ATP11A interactions | 7.64e-05 | 35 | 131 | 4 | int:ATP11A | |
| Interaction | SLC11A2 interactions | 1.06e-04 | 38 | 131 | 4 | int:SLC11A2 | |
| Interaction | KPNA4 interactions | 1.14e-04 | 225 | 131 | 8 | int:KPNA4 | |
| Interaction | GSTM1 interactions | 1.15e-04 | 15 | 131 | 3 | int:GSTM1 | |
| Interaction | GSTM4 interactions | 1.41e-04 | 16 | 131 | 3 | int:GSTM4 | |
| Interaction | LATS1 interactions | FBL USP9X RGPD1 RCN2 CMAS NEDD4 CEP350 DNAH12 SEC16A SLTM RAC1 | 1.44e-04 | 440 | 131 | 11 | int:LATS1 |
| Cytoband | 1p13.3 | 1.90e-06 | 69 | 134 | 5 | 1p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p13 | 4.04e-04 | 211 | 134 | 5 | chr1p13 | |
| GeneFamily | Glutathione S-transferases | 1.02e-05 | 25 | 100 | 4 | 567 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 4.26e-05 | 115 | 100 | 6 | 769 | |
| GeneFamily | C1-set domain containing | 8.39e-05 | 42 | 100 | 4 | 591 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 1.01e-04 | 44 | 100 | 4 | 588 | |
| GeneFamily | Rho family GTPases | 1.75e-04 | 20 | 100 | 3 | 390 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 1.51e-08 | 33 | 133 | 6 | MM477 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 7.96e-08 | 43 | 133 | 6 | MM3857 | |
| Coexpression | GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 8.66e-06 | 200 | 133 | 8 | M9164 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_DENDRITIC_CELLS | 1.42e-05 | 214 | 133 | 8 | M40005 | |
| Coexpression | WENG_POR_DOSAGE | 1.57e-05 | 30 | 133 | 4 | MM1199 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_HEMATOPOIETIC_PRECURSOR_CELL_AGEING | 2.60e-05 | 114 | 133 | 6 | MM3799 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_VEIN_ENDOTHELIAL_CELL_AGEING | 2.72e-05 | 12 | 133 | 3 | MM3776 | |
| Coexpression | GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_UP | 7.26e-05 | 199 | 133 | 7 | M9238 | |
| Coexpression | GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY7_UP | 7.49e-05 | 200 | 133 | 7 | M9319 | |
| Coexpression | HALLMARK_APICAL_JUNCTION | 7.49e-05 | 200 | 133 | 7 | M5915 | |
| Coexpression | GSE17721_0.5H_VS_12H_POLYIC_BMDC_DN | 7.49e-05 | 200 | 133 | 7 | M4087 | |
| Coexpression | GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN | 8.76e-05 | 46 | 133 | 4 | M11636 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.99e-08 | 173 | 132 | 8 | efb8072475000888efe088d00e870c56ffad4172 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.21e-08 | 174 | 132 | 8 | 58300d64d3b6fd9ba1b6c87ea83b2777eb6be2f4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-07 | 190 | 132 | 8 | 0a944da2aaaef9289b2a4ffe360b0338724fd59b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.36e-07 | 197 | 132 | 8 | b597c292fc1cb381a4325fed15a32966c38def28 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D122|Adult / Lineage, Cell type, age group and donor | 3.02e-07 | 148 | 132 | 7 | 81a1e6fdd942a612bf523c59b8b4974f6ca1fdce | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Biphasic-6|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 4.91e-07 | 159 | 132 | 7 | 85501c636cd04f15ba1be24df1ba7ac909633ce8 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.51e-06 | 188 | 132 | 7 | 9fc3819aae5a2b2534cb131d467435b5cfc420d6 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.51e-06 | 188 | 132 | 7 | 5e5d779ea079d3b2a1ef650b06b9f5cc1ffef5e7 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.68e-06 | 191 | 132 | 7 | 9431ffd6b758f756609d9057de2023596e22b5d4 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-06 | 195 | 132 | 7 | 97a9410f47beca02346902d078288a75bfe6e56b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.99e-06 | 196 | 132 | 7 | e54c08f88779f9fd453a4f5b85aed1f460d8a1e1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.13e-06 | 198 | 132 | 7 | 00a54af5267bfe0eeab6720bf890dc4b6b803bfd | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.20e-06 | 199 | 132 | 7 | 5919933c4b842b98fc98685dc8c72c8dd32c6ea3 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.20e-06 | 199 | 132 | 7 | caf2e050b21e7a16ce4e51b3f135debd06810231 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-TRAM-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.28e-06 | 200 | 132 | 7 | b92804f15586e1802fdd931d6dfe742be8466944 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.33e-06 | 148 | 132 | 6 | 80470353e12599440f711b6e107730763376d04d | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_macrophage-Langerhans_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.48e-06 | 157 | 132 | 6 | 10341ed8cbee0f636770a82cf580f6453bee8596 | |
| ToppCell | BAL-Mild-cDC_5|Mild / Compartment, Disease Groups and Clusters | 8.63e-06 | 161 | 132 | 6 | 7a6e8ed0b5d999efce8945d8083ab01d71be9a92 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.63e-06 | 161 | 132 | 6 | dccb61d5e17a8f1c6d1fc146ee389f567659a0f0 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.26e-06 | 163 | 132 | 6 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-05 | 166 | 132 | 6 | 83d0c26ccee605df6b04bbca31661bf4ff4f22ba | |
| ToppCell | CV-Mild-6|CV / Virus stimulation, Condition and Cluster | 1.06e-05 | 167 | 132 | 6 | cf2ed0b6d17a16f9a2318879ce8856d5983ad3cf | |
| ToppCell | Dendritic_Cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.10e-05 | 168 | 132 | 6 | 33618e5dbcee31f30afacacc9f6046782c100fb3 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.18e-05 | 170 | 132 | 6 | a6fa0cab1fa829ec601fe48306b4c43c83425b04 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.18e-05 | 170 | 132 | 6 | b40255eee45eb18b5a297336d7f3845fd8f8aa3b | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-05 | 171 | 132 | 6 | 714a0b0d0c9886fef64170cf53eb64f0d8a47280 | |
| ToppCell | (07)_Ionocytes-(2)_GFP_FOXI1|(07)_Ionocytes / shred by cell type by condition | 1.26e-05 | 172 | 132 | 6 | 5776b638b845d054f6e884e7df0412477f48517d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.30e-05 | 173 | 132 | 6 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | FLU-Healthy-5|Healthy / Virus stimulation, Condition and Cluster | 1.30e-05 | 173 | 132 | 6 | 8c218ec1ba927e9312f3df5f312395e907ab64ab | |
| ToppCell | FLU-Healthy-5|FLU / Virus stimulation, Condition and Cluster | 1.30e-05 | 173 | 132 | 6 | bd4f06d971f9d138749094047c9337dfbaf5da31 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-05 | 174 | 132 | 6 | 778e0317c0c63fa4efd74114feb760975b819d92 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-05 | 177 | 132 | 6 | 345cebc19f93970a9a46be139208b300081f5493 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-05 | 177 | 132 | 6 | 4553ee8cd9c24db6511b09fe49ed11a89e7cde9e | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.48e-05 | 177 | 132 | 6 | c5e829bc4594761666d65cace5a9c5d19c16f187 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-05 | 183 | 132 | 6 | a97f052950429245c3231464271e1ba539863bba | |
| ToppCell | COVID-19-APC-like-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 1.79e-05 | 183 | 132 | 6 | 703364836b42aa6ac6c68b42b700ac23c4a1afc7 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.79e-05 | 183 | 132 | 6 | b4f29dd3994009bb5eb769d36d95886664e7f87d | |
| ToppCell | COVID-19-APC-like|COVID-19 / group, cell type (main and fine annotations) | 1.79e-05 | 183 | 132 | 6 | b8f5afaf9ff1b2b1bc60be58654d1b23859dafa9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.90e-05 | 185 | 132 | 6 | 76fc5bbb71e42c0eb70474efcd3a71a7b2633f24 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-B_cells-Memory_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-05 | 186 | 132 | 6 | b5e094850ac3785775393cd78a939b02339732b0 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.02e-05 | 187 | 132 | 6 | 8249b2a69c728e4e04fb14b490c320e644d2252f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.02e-05 | 187 | 132 | 6 | 2a7226adb4d15b92936603bdf05421c50b21f003 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.02e-05 | 187 | 132 | 6 | 00930e407beaa337f72533a69f32d150faad8b9a | |
| ToppCell | Control-Lymphoid_B-B_memory|Control / Disease group, lineage and cell class | 2.08e-05 | 188 | 132 | 6 | ba4245de3bee29118abab57c4fce60b2007a189c | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-B_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-05 | 188 | 132 | 6 | 7b56c680e9f1851cb961b0f8faeeb987685ae36d | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Promonocyte-like|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.08e-05 | 188 | 132 | 6 | 2ae945d96a011f246d04a42bcd6ef443232b03f4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.08e-05 | 188 | 132 | 6 | ef3f6400c018834a8fd56893faa3476a0f10aedc | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-MMP9+_Inflammatory_macrophage|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-05 | 188 | 132 | 6 | f955f2eb92f399958d4d713e31af77d93fb4a6ec | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-05 | 189 | 132 | 6 | 389ccb68acb82893709f256315111470cf4beed3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-05 | 189 | 132 | 6 | cd4746ea6ae48a7dd14a2960d38d9445a738cf2c | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_3|COVID-19_Convalescent / Disease condition and Cell class | 2.14e-05 | 189 | 132 | 6 | 732e8dcffcb634ca2968f9170c9c4b31dd5d4206 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-05 | 189 | 132 | 6 | 58465b9407fbce91cca8f199950d6e0054c38fbc | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-05 | 189 | 132 | 6 | b4b93bd10b7e3cc16e54ff73beac230f519c010a | |
| ToppCell | Multiciliated|World / shred by cell class for nasal brushing | 2.14e-05 | 189 | 132 | 6 | 34b110aef839376228c5a403a6b5047a945f472b | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-05 | 189 | 132 | 6 | 7ac78441a15a82218deaafd47accff2ea5c8de20 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-05 | 190 | 132 | 6 | d4f954e0748898df69e1710df558564db703dd61 | |
| ToppCell | B_cells-Memory_B_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.34e-05 | 192 | 132 | 6 | eef591095921ede098f41a2b81897b18915bb753 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.41e-05 | 193 | 132 | 6 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.41e-05 | 193 | 132 | 6 | 323d1f3f4fbeb93ba857fc135d8aa0b897f98ac5 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CCL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.41e-05 | 193 | 132 | 6 | 21a117cceb562439ca3fe129aad8cac5f5728b1f | |
| ToppCell | B_cells-Activate_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.41e-05 | 193 | 132 | 6 | b6da81920cf2e55f87ec8d4b2b5530cbf7ba2155 | |
| ToppCell | critical-Epithelial-Ciliated-diff|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.48e-05 | 194 | 132 | 6 | 176090949b53c043c58df63ad8cf4f486b350bdc | |
| ToppCell | (7)_DC_2|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.55e-05 | 195 | 132 | 6 | 63abdf512368a32e586f8dc87090796f19a146c6 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-B_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-05 | 195 | 132 | 6 | e3df097e894b96b7d23db35bd527a8de6a055e52 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-B_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-05 | 195 | 132 | 6 | 8f5dfcdaccb0c8318f90a33519a8d6d98ba22943 | |
| ToppCell | 367C-Myeloid-Monocyte-CD14+_Monocyte|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.55e-05 | 195 | 132 | 6 | 4f9e26e033353fc9a8bdbd10358ee68ab2291880 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-cDC2-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.55e-05 | 195 | 132 | 6 | a2fe352682f548001ca2ee056e7a54af10134453 | |
| ToppCell | severe-Lymphocytic-B_cells_1|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.55e-05 | 195 | 132 | 6 | 73e39005a597e13aea571ae6ae5824d1c7448b71 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-B_cells-Naive_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-05 | 195 | 132 | 6 | 630bfe5b192d247bab7cf8bc5a0780c7f8d67501 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-B_cells-Memory_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-05 | 195 | 132 | 6 | e98217f9cf8c9574af66a1d8953101119c89c8a1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-05 | 195 | 132 | 6 | 42bfdff88da1d07828c0ad65d412fb1752f0cee4 | |
| ToppCell | ILEUM-inflamed|ILEUM / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.55e-05 | 195 | 132 | 6 | 661962a8bcd2b69894e889cb0681a5b0cdb8e819 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-MMP9+_Inflammatory_macrophage|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-05 | 195 | 132 | 6 | 5a7c74f96f213c504abd65e751800da7e03e47d9 | |
| ToppCell | 10x5'v1-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 2.63e-05 | 196 | 132 | 6 | 31229affb48521e8be93b6061178fd8cea09ba99 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.63e-05 | 196 | 132 | 6 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.63e-05 | 196 | 132 | 6 | b15812354128c12a588d79ef449d787e74835f3b | |
| ToppCell | 367C-Myeloid-Monocyte|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.63e-05 | 196 | 132 | 6 | 202066aeb837659fcc2e127fb52d7189e2e3520d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-05 | 196 | 132 | 6 | 291c59b609985167c98a40d4e2caeea2fad74941 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.63e-05 | 196 | 132 | 6 | a692cee9254f3771a076b290688a4d0120c02c3b | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-B_cells-Memory_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.70e-05 | 197 | 132 | 6 | 5b172bc2f3f6bd4741600e1ea299c469685eba4f | |
| ToppCell | 10x5'-Liver-Myeloid_Monocytic-Nonclassical_monocytes|Liver / Manually curated celltypes from each tissue | 2.70e-05 | 197 | 132 | 6 | b0b4a704e1137f48e2258df17285ed89684ae98d | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.70e-05 | 197 | 132 | 6 | e2c53742c7d8d1b63d93843f82330b9e20f1faa6 | |
| ToppCell | ILEUM-inflamed-(3)_MNP|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.70e-05 | 197 | 132 | 6 | b105bad5ac85961919a654a38587d1017973c981 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.70e-05 | 197 | 132 | 6 | 85b5d284e7799335a1829a5d2d56bb0845f5cec5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-05 | 197 | 132 | 6 | d95565652ca318a2298d6918d54ba6367e9560f4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-05 | 197 | 132 | 6 | 826cc6baafab13e7ef5cfcf28cd79d0fbf3af38d | |
| ToppCell | ICU-SEP-Myeloid-CD16_Mono|ICU-SEP / Disease, Lineage and Cell Type | 2.78e-05 | 198 | 132 | 6 | 3e6f262ec71e99a5dadbaaeaff1b4f1894907c7d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.78e-05 | 198 | 132 | 6 | b50074297184bcc044d06e20bb1d3733b9bd8df7 | |
| ToppCell | ASK440-Immune-Macrophages|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.78e-05 | 198 | 132 | 6 | 618025886ab130ce4cdc3461bd5c06643a8e204d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-05 | 198 | 132 | 6 | 953630dbe3154b1b102b87de0feca2cbf124eabe | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.78e-05 | 198 | 132 | 6 | 3bc05b8d97a7219af40db7a11aa271f02e74fca5 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.78e-05 | 198 | 132 | 6 | 41e8a7894f52f3a5f8f24575b3f6e205429489b2 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-05 | 198 | 132 | 6 | 8e45551224fbb30c0658ad47dd98335ecf165437 | |
| ToppCell | BLOOD--(3)_Intermediate_monocytes| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.78e-05 | 198 | 132 | 6 | 61685a86f70a7d2a6d3260b76081119978c15661 | |
| ToppCell | ASK428-Immune-Macrophages|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.78e-05 | 198 | 132 | 6 | fe7d60fa31222ec601bef1d72801803e5b549558 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.86e-05 | 199 | 132 | 6 | a1635a52318be0423f8e4fc03d971c28cd22b57e | |
| ToppCell | ASK454-Immune-B_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.86e-05 | 199 | 132 | 6 | cbfabf8e895abe454606b990f99e3738f4263ffe | |
| ToppCell | wk_15-18-Hematologic-Myeloid-SPP1+_Mac|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.86e-05 | 199 | 132 | 6 | c7fc2ac1601346aac71e7620a8a440fde8d92dbd | |
| ToppCell | ASK454-Immune-B_cell|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.86e-05 | 199 | 132 | 6 | b9b0ae81b9e7e35023c73d3b936e88167461ba54 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-TRAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.94e-05 | 200 | 132 | 6 | ecd2b9a7d464792b77381d0a0bc7030e77ad3581 | |
| Computational | ROS metabolism. | 3.41e-05 | 22 | 93 | 4 | MODULE_310 | |
| Computational | Genes in the cancer module 101. | 7.20e-05 | 10 | 93 | 3 | MODULE_101 | |
| Computational | Genes in the cancer module 132. | 2.13e-04 | 14 | 93 | 3 | MODULE_132 | |
| Drug | EUK-189 | 1.92e-06 | 16 | 133 | 4 | ctd:C436526 | |
| Drug | triadimefon | SULT1E1 GSTM1 GSTM4 ELL2 MICAL2 MAMDC2 CAPN7 CYP2U1 BAIAP2 FGL1 ALPK2 RAC2 | 3.13e-06 | 389 | 133 | 12 | ctd:C032910 |
| Drug | Clch2cosg | 3.20e-06 | 18 | 133 | 4 | CID000163913 | |
| Drug | C14791 | 3.20e-06 | 18 | 133 | 4 | CID011954044 | |
| Drug | C14793 | 3.20e-06 | 18 | 133 | 4 | CID011954046 | |
| Drug | C14803 | 3.20e-06 | 18 | 133 | 4 | CID011954054 | |
| Drug | C14805 | 3.20e-06 | 18 | 133 | 4 | CID011954056 | |
| Drug | C14804 | 3.20e-06 | 18 | 133 | 4 | CID011954055 | |
| Drug | C14806 | 3.20e-06 | 18 | 133 | 4 | CID011954057 | |
| Drug | C14848 | 3.20e-06 | 18 | 133 | 4 | CID011954067 | |
| Drug | C14856 | 3.20e-06 | 18 | 133 | 4 | CID011954069 | |
| Drug | C14855 | 3.20e-06 | 18 | 133 | 4 | CID011954068 | |
| Drug | S-(2,2-dichloro-1-hydroxy)ethylglutathione | 3.20e-06 | 18 | 133 | 4 | CID011954070 | |
| Drug | AC1L4MYY | 3.20e-06 | 18 | 133 | 4 | CID000188517 | |
| Drug | B258 | 3.85e-06 | 6 | 133 | 3 | CID000593690 | |
| Drug | 1-chloro-2,4-dinitrobenzene-glutathione conjugate | 3.85e-06 | 6 | 133 | 3 | ctd:C042630 | |
| Drug | 2-(S-glutathionyl) acetyl glutathione | 5.01e-06 | 20 | 133 | 4 | CID011954072 | |
| Drug | C14865 | 5.01e-06 | 20 | 133 | 4 | CID011954073 | |
| Drug | Palladium | 6.70e-06 | 7 | 133 | 3 | ctd:D010165 | |
| Drug | C14802 | 7.95e-06 | 47 | 133 | 5 | CID011954053 | |
| Drug | C14800 | 8.83e-06 | 48 | 133 | 5 | CID011954051 | |
| Drug | bromobenzene-3,4-oxide | 9.78e-06 | 49 | 133 | 5 | CID000108121 | |
| Drug | S-(formylmethyl)glutathione | 1.08e-05 | 24 | 133 | 4 | CID011954074 | |
| Drug | bromobenzene-2,3-oxide | 1.08e-05 | 50 | 133 | 5 | CID003036760 | |
| Drug | 1,1-dichloroethylene epoxide | 1.08e-05 | 50 | 133 | 5 | CID000119521 | |
| Drug | strychnine HCl | 1.15e-05 | 181 | 133 | 8 | CID000005304 | |
| Drug | naphthalene epoxide | 1.19e-05 | 51 | 133 | 5 | CID000108063 | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; PC3; HT_HG-U133A | 1.40e-05 | 186 | 133 | 8 | 4271_UP | |
| Drug | dichloroacetaldehyde | 1.59e-05 | 54 | 133 | 5 | CID000006576 | |
| Drug | chloroacetyl chloride | 1.74e-05 | 55 | 133 | 5 | CID000006577 | |
| Drug | AC1Q608X | 2.04e-05 | 28 | 133 | 4 | CID000128466 | |
| Drug | AC1L33DC | 2.04e-05 | 28 | 133 | 4 | CID000133757 | |
| Drug | Retrorsine [480-54-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 2.04e-05 | 196 | 133 | 8 | 2784_UP | |
| Drug | alpha-Santonin [481-06-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 2.12e-05 | 197 | 133 | 8 | 3877_DN | |
| Drug | bromoacetaldehyde | 2.25e-05 | 58 | 133 | 5 | CID000105131 | |
| Drug | 2-BHA | 2.36e-05 | 29 | 133 | 4 | CID000006932 | |
| Drug | chlorpyrifos | 2.85e-05 | 101 | 133 | 6 | CID000002730 | |
| Drug | BP-4,5-oxide | 2.89e-05 | 61 | 133 | 5 | CID000037786 | |
| Drug | Dcvg | 3.10e-05 | 31 | 133 | 4 | CID006437359 | |
| Drug | o-dinitrobenzene | 3.10e-05 | 31 | 133 | 4 | CID000010707 | |
| Drug | Glutathione S-(2,4 Dinitrobenzene) | 3.39e-05 | 2 | 133 | 2 | DB02458 | |
| Drug | AC1O1I54 | 3.39e-05 | 2 | 133 | 2 | CID000516928 | |
| Drug | m-toluidine | 4.50e-05 | 34 | 133 | 4 | CID000007934 | |
| Drug | Lyndiol | 4.50e-05 | 34 | 133 | 4 | CID000082149 | |
| Drug | dimethoxystrychnine | 5.06e-05 | 35 | 133 | 4 | CID000009649 | |
| Drug | Dixan | 5.06e-05 | 35 | 133 | 4 | CID000010404 | |
| Drug | Glutathione | 5.67e-05 | 36 | 133 | 4 | DB00143 | |
| Drug | 1,2-dibromoethane | 6.03e-05 | 71 | 133 | 5 | CID000007839 | |
| Drug | Creosote | 7.04e-05 | 38 | 133 | 4 | ctd:D003407 | |
| Drug | CoCl2 | 7.84e-05 | 75 | 133 | 5 | CID003015678 | |
| Drug | Ethoxyquin | 8.64e-05 | 40 | 133 | 4 | ctd:D005015 | |
| Drug | BP-7,8-diol | 9.46e-05 | 78 | 133 | 5 | CID000025892 | |
| Drug | 1-(2-trifluoromethoxyphenyl)-2-nitroethanone | 1.06e-04 | 184 | 133 | 7 | ctd:C576882 | |
| Drug | Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | 1.43e-04 | 193 | 133 | 7 | 4315_DN | |
| Drug | 4-hydroxyanisole | 1.50e-04 | 46 | 133 | 4 | CID000009015 | |
| Drug | Chicago sky blue 6B [2610-05-1]; Up 200; 4uM; MCF7; HT_HG-U133A | 1.52e-04 | 195 | 133 | 7 | 3266_UP | |
| Drug | Trioxsalen [3902-71-4]; Up 200; 17.6uM; PC3; HT_HG-U133A | 1.57e-04 | 196 | 133 | 7 | 5736_UP | |
| Drug | Cholecalciferol [67-97-0]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 1.57e-04 | 196 | 133 | 7 | 3298_DN | |
| Drug | Streptomycin sulfate [3810-74-0]; Down 200; 2.8uM; HL60; HG-U133A | 1.62e-04 | 197 | 133 | 7 | 1578_DN | |
| Drug | PHA-00816795 [212631-79-3]; Up 200; 10uM; PC3; HT_HG-U133A | 1.67e-04 | 198 | 133 | 7 | 7076_UP | |
| Drug | Amitryptiline hydrochloride [549-18-8]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.67e-04 | 198 | 133 | 7 | 5453_UP | |
| Drug | trichloroethylene | 1.68e-04 | 88 | 133 | 5 | CID000006575 | |
| Drug | Fluphenazine dihydrochloride [146-56-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 7234_UP | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; MCF7; HT_HG-U133A | 1.72e-04 | 199 | 133 | 7 | 4346_DN | |
| Drug | PF-00562151-00 [351320-12-2]; Down 200; 10uM; PC3; HT_HG-U133A | 1.78e-04 | 200 | 133 | 7 | 6907_DN | |
| Drug | Edrophonium chloride [116-38-1]; Down 200; 19.8uM; MCF7; HT_HG-U133A | 1.78e-04 | 200 | 133 | 7 | 1519_DN | |
| Drug | NSC9567 | 1.82e-04 | 141 | 133 | 6 | CID000003001 | |
| Drug | Haloperidol | 1.86e-04 | 342 | 133 | 9 | ctd:D006220 | |
| Drug | sulfolithocholic acid | 2.02e-04 | 4 | 133 | 2 | ctd:C014202 | |
| Drug | 4-chloronitrobenzene | 2.02e-04 | 4 | 133 | 2 | ctd:C010407 | |
| Drug | phenanthroline | 2.08e-04 | 50 | 133 | 4 | CID000067473 | |
| Disease | Brugada syndrome (implicated_via_orthology) | 1.74e-09 | 5 | 129 | 4 | DOID:0050451 (implicated_via_orthology) | |
| Disease | autosomal dominant intellectual developmental disorder 48 (implicated_via_orthology) | 8.16e-08 | 3 | 129 | 3 | DOID:0080235 (implicated_via_orthology) | |
| Disease | C-C motif chemokine 19 measurement | 3.37e-07 | 14 | 129 | 4 | EFO_0008047 | |
| Disease | Epstein Barr virus nuclear antigen 1 IgG measurement | 6.73e-06 | 9 | 129 | 3 | EFO_0007790 | |
| Disease | HLA class II histocompatibility antigen, DQ alpha 2 chain measurement | 6.73e-06 | 9 | 129 | 3 | EFO_0801686 | |
| Disease | CCL19 measurement | 9.58e-06 | 10 | 129 | 3 | EFO_0009415 | |
| Disease | Alzheimer disease, family history of Alzheimer’s disease | 1.44e-05 | 119 | 129 | 6 | EFO_0009268, MONDO_0004975 | |
| Disease | family history of Alzheimer’s disease | 1.53e-05 | 71 | 129 | 5 | EFO_0009268 | |
| Disease | level of glutathione S-transferase mu 1 in blood serum | 1.90e-05 | 2 | 129 | 2 | OBA_2041806 | |
| Disease | HIV infection | 1.90e-05 | 2 | 129 | 2 | EFO_0000764 | |
| Disease | 3,7-dimethylurate measurement | 1.90e-05 | 2 | 129 | 2 | EFO_0800949 | |
| Disease | Hantavirus hemorrhagic fever with renal syndrome (is_implicated_in) | 1.90e-05 | 2 | 129 | 2 | DOID:11266 (is_implicated_in) | |
| Disease | alcohol and nicotine codependence | 2.26e-05 | 13 | 129 | 3 | EFO_0004776 | |
| Disease | Degenerative Diseases, Central Nervous System | 2.55e-05 | 39 | 129 | 4 | C0270715 | |
| Disease | Neurodegenerative Disorders | 2.55e-05 | 39 | 129 | 4 | C0524851 | |
| Disease | Degenerative Diseases, Spinal Cord | 2.55e-05 | 39 | 129 | 4 | C0751733 | |
| Disease | autistic disorder (is_implicated_in) | 3.43e-05 | 42 | 129 | 4 | DOID:12849 (is_implicated_in) | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 3.77e-05 | 43 | 129 | 4 | DOID:9074 (implicated_via_orthology) | |
| Disease | Depressive disorder | 4.21e-05 | 289 | 129 | 8 | C0011581 | |
| Disease | response to interferon-beta, anti-drug antibody measurement | 5.31e-05 | 17 | 129 | 3 | EFO_0010559, GO_0035456 | |
| Disease | acute disseminated encephalomyelitis (is_implicated_in) | 5.67e-05 | 3 | 129 | 2 | DOID:639 (is_implicated_in) | |
| Disease | Multiple sclerosis, susceptibility to | 5.67e-05 | 3 | 129 | 2 | cv:C1868685 | |
| Disease | MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO | 5.67e-05 | 3 | 129 | 2 | 126200 | |
| Disease | neoplasm of mature B-cells | 8.81e-05 | 20 | 129 | 3 | EFO_0000096 | |
| Disease | renal fibrosis (is_marker_for) | 1.13e-04 | 4 | 129 | 2 | DOID:0050855 (is_marker_for) | |
| Disease | infectious mononucleosis (is_implicated_in) | 1.13e-04 | 4 | 129 | 2 | DOID:8568 (is_implicated_in) | |
| Disease | Henoch-Schoenlein purpura | 1.18e-04 | 22 | 129 | 3 | EFO_1000965 | |
| Disease | ubiquitin carboxyl-terminal hydrolase 25 measurement | 1.18e-04 | 22 | 129 | 3 | EFO_0021881 | |
| Disease | Mental Depression | 1.32e-04 | 254 | 129 | 7 | C0011570 | |
| Disease | hepatocyte nuclear factor 4-alpha measurement | 1.88e-04 | 5 | 129 | 2 | EFO_0801672 | |
| Disease | glutathione S-transferase Mu 1 measurement | 1.88e-04 | 5 | 129 | 2 | EFO_0801638 | |
| Disease | basal cell carcinoma | 1.89e-04 | 189 | 129 | 6 | EFO_0004193 | |
| Disease | lysophosphatidylethanolamine 16:0 measurement | 1.97e-04 | 26 | 129 | 3 | EFO_0010366 | |
| Disease | squamous cell carcinoma | 2.16e-04 | 67 | 129 | 4 | EFO_0000707 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.24e-04 | 195 | 129 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | 2.59e-04 | 477 | 129 | 9 | C0005586 | |
| Disease | pulmonary tuberculosis | 2.74e-04 | 29 | 129 | 3 | EFO_1000049 | |
| Disease | Schizoaffective Disorder | 2.74e-04 | 29 | 129 | 3 | C0036337 | |
| Disease | Human papillomavirus infectious disease (is_implicated_in) | 2.81e-04 | 6 | 129 | 2 | DOID:11166 (is_implicated_in) | |
| Disease | antibody measurement, Epstein-Barr virus infection | 2.81e-04 | 6 | 129 | 2 | EFO_0000769, EFO_0004556 | |
| Disease | pemphigus | 2.81e-04 | 6 | 129 | 2 | EFO_1000749 | |
| Disease | perceived unattractiveness to mosquitos measurement | 2.85e-04 | 72 | 129 | 4 | EFO_0008380 | |
| Disease | self rated health | 3.35e-04 | 31 | 129 | 3 | EFO_0004778 | |
| Disease | tumor necrosis factor receptor superfamily member 6 measurement | 3.93e-04 | 7 | 129 | 2 | EFO_0010610 | |
| Disease | Drug-Induced Liver Disease | 4.16e-04 | 404 | 129 | 8 | C0860207 | |
| Disease | Drug-Induced Acute Liver Injury | 4.16e-04 | 404 | 129 | 8 | C3658290 | |
| Disease | Hepatitis, Toxic | 4.16e-04 | 404 | 129 | 8 | C0019193 | |
| Disease | Chemically-Induced Liver Toxicity | 4.16e-04 | 404 | 129 | 8 | C4279912 | |
| Disease | Chemical and Drug Induced Liver Injury | 4.16e-04 | 404 | 129 | 8 | C4277682 | |
| Disease | Hepatitis, Drug-Induced | 4.16e-04 | 404 | 129 | 8 | C1262760 | |
| Disease | bullous pemphigoid | 4.42e-04 | 34 | 129 | 3 | EFO_0007187 | |
| Disease | eosinophil percentage of leukocytes | FLI1 PDCD1 HLA-DQB2 HLA-DRB1 INPP5D HLA-DRB5 SBNO2 SUOX MBD5 CNN2 ALPK2 | 4.48e-04 | 746 | 129 | 11 | EFO_0007991 |
| Disease | total lipids in small HDL measurement | 4.82e-04 | 35 | 129 | 3 | EFO_0022311 | |
| Disease | IgG index | 5.22e-04 | 8 | 129 | 2 | EFO_0006929 | |
| Disease | urticaria (is_implicated_in) | 5.22e-04 | 8 | 129 | 2 | DOID:1555 (is_implicated_in) | |
| Disease | optic neuritis (is_implicated_in) | 5.22e-04 | 8 | 129 | 2 | DOID:1210 (is_implicated_in) | |
| Disease | IgG digalactosylation measurement | 5.22e-04 | 8 | 129 | 2 | EFO_0008424 | |
| Disease | interleukin-21 measurement | 5.22e-04 | 8 | 129 | 2 | EFO_0801724 | |
| Disease | phospholipids in small HDL measurement | 6.16e-04 | 38 | 129 | 3 | EFO_0022296 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 6.41e-04 | 330 | 129 | 7 | EFO_0004529, EFO_0004612 | |
| Disease | Alzheimer disease, peptic ulcer disease | 6.65e-04 | 39 | 129 | 3 | MONDO_0004247, MONDO_0004975 | |
| Disease | central nervous system non-hodgkin lymphoma | 6.69e-04 | 9 | 129 | 2 | MONDO_0044887 | |
| Disease | seropositivity measurement | 6.69e-04 | 9 | 129 | 2 | EFO_0007034 | |
| Disease | factor VIII measurement | 7.17e-04 | 40 | 129 | 3 | EFO_0004630 | |
| Disease | kidney disease (implicated_via_orthology) | 7.71e-04 | 41 | 129 | 3 | DOID:557 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 8.05e-04 | 447 | 129 | 8 | C3714756 | |
| Disease | peptidoglycan recognition protein 1 measurement | 8.34e-04 | 10 | 129 | 2 | EFO_0020624 | |
| Disease | IgG sialylation measurement | 8.34e-04 | 10 | 129 | 2 | EFO_0008428 | |
| Disease | Familial Alzheimer Disease (FAD) | 9.89e-04 | 100 | 129 | 4 | C0276496 | |
| Disease | cAMP-specific 3',5'-cyclic phosphodiesterase 4D measurement | 1.02e-03 | 11 | 129 | 2 | EFO_0020224 | |
| Disease | aspirin-induced respiratory disease (is_implicated_in) | 1.02e-03 | 11 | 129 | 2 | DOID:0080822 (is_implicated_in) | |
| Disease | Alzheimer's Disease | 1.03e-03 | 101 | 129 | 4 | C0002395 | |
| Disease | rac GTPase-activating protein 1 measurement | 1.22e-03 | 12 | 129 | 2 | EFO_0801985 | |
| Disease | anti-Epstein Barr virus antibody measurement | 1.22e-03 | 12 | 129 | 2 | EFO_0009273 | |
| Disease | apolipoprotein A 1 measurement | MAP1A NEIL2 HLA-DQB2 HLA-DRB5 RSPRY1 GSTM1 GSTM2 GSTM5 COLEC11 RAC1 SORL1 | 1.27e-03 | 848 | 129 | 11 | EFO_0004614 |
| Disease | alcohol dependence | 1.29e-03 | 183 | 129 | 5 | MONDO_0007079 | |
| Disease | rheumatoid arthritis, smoking status measurement, ACPA-positive rheumatoid arthritis | 1.43e-03 | 13 | 129 | 2 | EFO_0000685, EFO_0006527, EFO_0009459 | |
| Disease | mood disorder | 1.43e-03 | 13 | 129 | 2 | EFO_0004247 | |
| Disease | Vitiligo, response to rhododendrol | 1.43e-03 | 13 | 129 | 2 | EFO_0004208, EFO_0010824 | |
| Disease | autoimmune hepatitis (is_implicated_in) | 1.43e-03 | 13 | 129 | 2 | DOID:2048 (is_implicated_in) | |
| Disease | complement C4 measurement | 1.54e-03 | 52 | 129 | 3 | EFO_0004984 | |
| Disease | Spastic Paraplegia, Hereditary | 1.67e-03 | 14 | 129 | 2 | C0037773 | |
| Disease | oligoclonal band measurement, multiple sclerosis | 1.67e-03 | 14 | 129 | 2 | EFO_0005206, MONDO_0005301 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.81e-03 | 291 | 129 | 6 | EFO_0008317, EFO_0020946 | |
| Disease | keratinocyte carcinoma | 1.82e-03 | 118 | 129 | 4 | EFO_0010176 | |
| Disease | Non-steroidal anti-inflammatory and antirheumatic product use measurement | 1.92e-03 | 15 | 129 | 2 | EFO_0009935 | |
| Disease | allergic disease (is_implicated_in) | 1.92e-03 | 15 | 129 | 2 | DOID:1205 (is_implicated_in) | |
| Disease | IGA glomerulonephritis | 2.11e-03 | 58 | 129 | 3 | EFO_0004194 | |
| Disease | FEV change measurement, response to bronchodilator | 2.11e-03 | 58 | 129 | 3 | EFO_0005921, GO_0097366 | |
| Disease | systemic lupus erythematosus, COVID-19 | 2.11e-03 | 58 | 129 | 3 | MONDO_0007915, MONDO_0100096 | |
| Disease | pemphigus vulgaris | 2.19e-03 | 16 | 129 | 2 | EFO_0004719 | |
| Disease | Urticaria | 2.19e-03 | 16 | 129 | 2 | C0042109 | |
| Disease | autism spectrum disorder (is_implicated_in) | 2.19e-03 | 16 | 129 | 2 | DOID:0060041 (is_implicated_in) | |
| Disease | cathepsin L1 measurement | 2.19e-03 | 16 | 129 | 2 | EFO_0010619 | |
| Disease | Sjogren syndrome | 2.33e-03 | 60 | 129 | 3 | EFO_0000699 | |
| Disease | anti-anoctamin 2 antibody measurement | 2.47e-03 | 17 | 129 | 2 | EFO_0010150 | |
| Disease | Amelogenesis imperfecta | 2.47e-03 | 17 | 129 | 2 | cv:C0002452 | |
| Disease | systemic lupus erythematosus (is_implicated_in) | 2.56e-03 | 62 | 129 | 3 | DOID:9074 (is_implicated_in) | |
| Disease | allergic sensitization measurement | 2.56e-03 | 62 | 129 | 3 | EFO_0005298 | |
| Disease | obesity (implicated_via_orthology) | 2.60e-03 | 215 | 129 | 5 | DOID:9970 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WKQADFGYARERLEE | 116 | Q5NDL2 | |
| KELQRDWPGYSEIDR | 266 | O00472 | |
| GNREWYDRILNDKSP | 571 | O94812 | |
| ESKEYRPGNWEAGNK | 1221 | Q86TB3 | |
| QEFIDNPKWYTDRGI | 206 | Q9Y276 | |
| LGLEAQEDEDPSYKW | 36 | Q12774 | |
| LGLEAQEDEDPSYKW | 36 | A5YM69 | |
| GLCDPNYKDVDWNDR | 31 | B4E2M5 | |
| SDYKLRWNPTDFGNI | 116 | Q15822 | |
| EDKDDPTTGAWRAAY | 386 | P55290 | |
| AWRYDKREDVQPGTG | 411 | Q9BV10 | |
| YARTQFVSPWKEGDE | 251 | O00203 | |
| FLGDYRWDPTANEDP | 211 | Q14257 | |
| ENTGPTLEWDNYDLR | 2216 | P49792 | |
| DDFDQFDKPGAERSW | 16 | Q96EV2 | |
| WDTAGQEDYDRLRPL | 56 | P15153 | |
| WDTAGQEDYDRLRPL | 56 | P60763 | |
| WDTAGQEDYDRLRPL | 56 | P63000 | |
| NTGPTLEWDNYDLRE | 1241 | Q99666 | |
| NTGPTLEWDNYDLRE | 1241 | O14715 | |
| LYEEIWKADRPGNAA | 271 | Q7Z304 | |
| WAQYRQGEARFLPKD | 31 | Q13231 | |
| NGDKYDGDWVRDRRQ | 151 | Q5T089 | |
| VDREDAPVRWYKDGQ | 831 | O75147 | |
| APVRWYKDGQEVEES | 836 | O75147 | |
| QVYDREADKWSRGVD | 566 | Q8N4N3 | |
| GRAREQEEKYWRGQD | 1631 | P78559 | |
| ELGRPDAEYWNSQKD | 81 | Q30154 | |
| PGWEEKQDERGRSYY | 771 | P46934 | |
| IRTDWDAGFKEGRQY | 111 | P52298 | |
| EYLERDAPAGDAGRW | 116 | Q969S2 | |
| NDPGWLKTFNDYFRD | 176 | Q16706 | |
| GDAPDYDRSQWLNEK | 36 | P46439 | |
| QNGDFPRWGDYEDKR | 436 | Q09327 | |
| DEEVRQGLKAYSNWP | 286 | O76003 | |
| KWSYEDKDQRPLNGF | 426 | Q96T76 | |
| TWYREDQPLSAGDEV | 2791 | Q8NDA2 | |
| LGQEETDWFDKPRDA | 3576 | Q9UPA5 | |
| GRSIEDWNNYKDFLE | 86 | P05538 | |
| DQGREYDKEGNLRPW | 656 | P0DPD6 | |
| VDYGELDFQWREKTP | 221 | Q15116 | |
| SEGDDKIEYRAWNPF | 126 | P22087 | |
| GDAPDYDRSQWLNEK | 36 | P28161 | |
| ARWDRESGLLAEQYP | 3001 | Q6ZR08 | |
| EWRQLDPDEKIAYGD | 21 | Q13401 | |
| FKDRVSWDGNPERYD | 91 | O60487 | |
| YWTAAQPADRKRDAE | 751 | Q86VP3 | |
| DAKNNRYSGWPAEIQ | 211 | P58499 | |
| TDAQDYDRRADKPWT | 651 | Q8IZ21 | |
| QESIRYAPGDAVEKW | 466 | Q9H0A0 | |
| FTENIGKPRYAETWD | 1641 | P78509 | |
| EGPRWKQAEDIRDIY | 6 | Q14012 | |
| NRFEEVAWSKYNPRD | 586 | Q9NZ94 | |
| ENTGPTLEWDNYDLR | 1241 | A6NKT7 | |
| WEKPEDFYPNRFLDD | 456 | Q7Z449 | |
| KEGRDYNAPDSKWEI | 241 | Q7L622 | |
| RDRNSWGGFSEKTYE | 6 | Q8WXF7 | |
| GLWNFDRECNEKYGE | 56 | Q9HB55 | |
| KGRYSENDVKNWTPE | 486 | Q9Y6W3 | |
| RSDGSENFNRGWKDY | 126 | Q08830 | |
| GEQFVLEKGDYPRWD | 76 | P26998 | |
| VKEDPSYDSVRRGAW | 216 | Q01543 | |
| SRKDGRYLDDSWVNA | 76 | Q5VT06 | |
| ELGRPDAEYWNSQKD | 81 | P01911 | |
| NKWRSGEPNNAYDEE | 226 | Q9BWP8 | |
| ELGRPDAEYWNSQKD | 81 | P13762 | |
| QSPRGERNRWKYEEF | 1201 | Q9P267 | |
| ERNRWKYEEFLDHPG | 1206 | Q9P267 | |
| YGRPNWDNEFKTIAS | 511 | P04839 | |
| RGGYAAEKEERQQWE | 296 | Q8NEP3 | |
| NSPYLRGNTWDERDD | 611 | Q9NRM1 | |
| RDEDDPGKGNYWTLD | 186 | Q12951 | |
| QNFDYLSDWGPRFKR | 771 | P55286 | |
| KRDWPGVKADDRNDY | 66 | O94868 | |
| DGKYGARDPDTKAWN | 461 | P42261 | |
| GRQGDDEQSDWFYEK | 276 | Q9NW75 | |
| WPYADGDFFKNRNEI | 151 | Q8IXS0 | |
| EVWFDEKGDAPGRYD | 466 | Q13255 | |
| GKVYQWDDPDPRLFD | 956 | P49327 | |
| YDPEDWLQVDAATGR | 416 | P55291 | |
| LRPVDSWRKNYGENA | 626 | O94851 | |
| EVVNFEWTYPRKESG | 241 | P09619 | |
| EERGQEKCAQYWPSD | 636 | P18433 | |
| NTGPTLEWDNYDLRE | 1226 | P0DJD0 | |
| YGKDFNDIRQDFLPW | 286 | Q9BTC8 | |
| DNPRRYDSDDDLAWN | 341 | O60478 | |
| ADEVYAVDWSPDGQR | 456 | Q9NVX2 | |
| DGERNRWYKFDDGDV | 1891 | Q93008 | |
| TENDYKLWSPSDERG | 626 | Q92673 | |
| ESWANDPDYLKRQVG | 276 | Q96DX4 | |
| RPRRQDWDGELYENG | 201 | Q8NFW8 | |
| GPTLEWDNYDLREDA | 1236 | P0DJD1 | |
| PNGTWRNYKAEVRFE | 141 | Q8N5W9 | |
| RSYTLAGKEEWEVNP | 361 | Q96MK3 | |
| GDAPDYDRSQWLNEK | 36 | Q03013 | |
| GDAPDYDRSQWLNEK | 36 | P09488 | |
| WADVEARYPLFEGQE | 716 | P41250 | |
| DVDHRRDDPYWSENK | 731 | Q9NWH9 | |
| GDLNYRVDLPTWEAE | 586 | Q92835 | |
| KWYEEVRQGPSGSED | 561 | Q9Y2E8 | |
| RVTAEEAKEPWESGY | 1116 | Q9Y2G9 | |
| EWNEPSINFYKRRGA | 131 | P21673 | |
| QGQTDWPAVKSFYDR | 891 | Q9NT68 | |
| DPAEWGSKVEDRFYN | 56 | Q15506 | |
| YISGDEDRKGPWEEF | 651 | Q5SWA1 | |
| KSDQGWRRYDFQNPS | 101 | Q8TAQ2 | |
| DAYWPEAKRAALDER | 721 | Q15424 | |
| DGEDYSPWADRKAAQ | 306 | Q9UQB8 | |
| NTDGAEYNIEPLWRF | 141 | P78536 | |
| ASPSNWKDYDDREPR | 366 | Q8N957 | |
| KWRFEDSFGVDPYNV | 171 | Q96S66 | |
| YDPQKEAELRTWIEG | 26 | Q99439 | |
| EPFRDEPWYNQKTES | 321 | P98196 | |
| LWYDEGEERNRGNFP | 66 | A0A5A2 | |
| LREWKEPASYGRQDA | 406 | Q9Y2H5 | |
| RENWDSDYVFGRKLA | 336 | Q8NHY6 | |
| KYDRGREGAEIEPWE | 21 | Q92738 | |
| VTPEDAIYGWNFNRD | 76 | O95497 | |
| AFGDRPEKRDNNWRY | 1306 | O15027 | |
| YWDNVEAFQARPDDL | 26 | P49888 | |
| DDSYLVEAGDRQKRW | 281 | Q8N1W2 | |
| PEARGDDAWKVYFDE | 766 | O14795 | |
| EWLGDELERRPYTGN | 2421 | O00507 | |
| RQGVPNWDCDYYDEK | 376 | Q96GW9 | |
| RDEFWDTAPAFEGRK | 51 | Q9HAC8 | |
| NPKERGFWYDAEISR | 231 | Q96T88 | |
| REEWKCEGYFERQPG | 126 | Q96NI8 | |
| PLFDEREQEYKSWGS | 156 | Q96NI8 | |
| SYLEQGKEPWLADRE | 56 | Q969W8 | |
| SEWKPYRDTEDREAF | 176 | Q8NEK5 | |
| LDWDEKRPEFVRGYN | 136 | Q96DR4 | |
| QRRDYKGFSPSVDWE | 396 | P51687 | |
| YKWSGFTEQDDRRGI | 526 | Q5T5U3 | |
| ASQEPVGRWDQDYDR | 41 | Q6IBS0 | |
| WIYPDEYQADGRQDR | 76 | Q96RE9 | |
| ADGYPIWSRQDDIDL | 356 | Q9NYB0 | |
| DYDNRWVSIFSPEGK | 551 | O75382 |